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Abstract
Ionotropic glutamate receptors (iGluRs) are key mediators of neuronal communica-
tion and synaptic plasticity. They are implicated in cellular mechanisms for learning
and memory and can be found in the nervous systems of a diverse array of biologi-
cal organisms from the complex brains in humans to the much simpler nerve nets in
ctenophores. At excitatory synapses, these ligand gated ion channels sense the release
of glutamate by presynaptic neurons and bind glutamate, triggering conformational
change in the ligand binding domains (LBD) that opens the channel pore to allow
current flow into the post synaptic neuron. Here we examine the molecular mech-
anisms of two processes involved in glutamate receptor activation - ligand binding
and LBD domain closure. In the AMPA receptor, a glutamate receptor subtype, we
present the first simulations of ligand binding in an iGluR and identified metastable
binding sites, which facilitate the diffusion of ligand into the binding pocket. We also
applied the string method, a chain-of-states pathway sampling method, to investi-
gate AMPA receptor glutamate binding and found that surprisingly, the ligand may
bind via at least two distinct pathways. In ctenophore glutamate receptors, early
ancestors of NMDA receptors in humans, we calculated the free energy landscape of
conformational change to explain puzzling changes in kinetics and thermodynamics
of a particularly high affinity glycine-binding domain. These findings both further
our understanding of glutamate receptor activation and have broader implications as
to the physical and chemical basis for neural activity.
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Chapter 1 - Introduction
1
1.1 iGluR structure
Ionotropic glutamate receptors are ion channels comprised of four subunits that
surround a central channel pore. Each subunit corresponds to an iGluR subtype,
which can be grouped into distinct classes based on their pharmacological properties:
the AMPA receptors with subtypes GluA1-GluA4, the Kainate receptors with sub-
types GluK1-GluK5, the NMDA receptors with subtypes GluN1, GluN2A-GluN2D,
GluN3A, and GluN3B, and the 𝛿 receptors with subtypes GluD1 and GluD2 [1].
Functional receptors are formed only with a subunit composition within the same
glutamate receptor class. Different classes are thought to play slightly different roles
in the complex mechanisms responsible for synaptic transmission. All the iGluRs
have a modular architecture in which the subunits are assembled in a "dimer-of-
dimers" fashion [2], and each subunit can be divided into three separate domains,
an amino-terminal domain (ATD), ligand-binding domain (LBD), transmembrame
domain (TMD) and C-terminal domain (CTD) Fig. 1-1. For the remainder of this
introduction, we will focus on only two of the iGluR classes: AMPA and NMDA
receptors.
The AMPA-type glutamate receptor can form both homo- and heteromers with
its varying subunits (GluA1-GluA4). The first crystal structure of an AMPA-type
iGluR homomer was solved by Sobolevsky et al. in 2009 [3], and more recently,
the heteromeric structure of an AMPA-type iGluR was solved by Herguedas et al.
in 2016 [4]. Both structures revealed that, broadly speaking, AMPA receptors are
two-fold symmetric and contain only two pairs of conformationally distinct subunits,
subunits AC and subunits BD, with subunit A being equivalent to subunit C and
subunit B being equivalent to subunit D. Conformational change in one region of
the receptor can be propagated throughout the entire receptor; in the LBD layer,
subunit A,B and subunit C,D form dimers, whereas in the ATD layer, subunit A,D
and subunit B,C form dimers. The binding of glutamate triggers conformational
change in the LBD layer, which is propagated to the TMD layer through the LBD
- TMD linkers, and opens the ion channel pore. The ATD layer is thought to be
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involved in the assembly of the tetrameric receptor and receptor trafficking [5–7], but
is nonessential to receptor function - AMPA receptor mutants that lack the ATD still
form functional channels [8, 9]. AMPA receptors are primarily responsible for fast
excitatory transmission in the central nervous system.
The NMDA-type glutamate receptors, on the other hand, are obligate heteromers
and require two GluN1 subunits to form functional channels. NMDA tetramers can
be composed of either two GluN1 subunits with two GluN2 subunits or a combi-
nation of GluN2 and GluN3 subunits. Unlike AMPA receptors, which require only
glutamate to activate, NMDA receptors require the binding of both glutamate and a
co-agonist, glycine, to activate. The LBDs of GluN2 subunits serve as the binding site
for glutamate, whereas the GluN1 and GluN3 LBDs subunits contain binding sites for
glycine. Glycine-activated NMDA receptor channels can be formed by tetramers of
only GluN1 of GluN3 subunits [10]; these channels have not been found to be present
in neurons [11]. One notable distinction of NMDA receptors is that under physio-
logical conditions, the channel pore is blocked by a Mg2+ ion, which is only released
once the membrane is depolarized. Thus, the majority of NMDA receptors exhibit
a voltage dependence and require both ligand binding and membrane depolarization
to activate. Only AMPA receptors which lack the GluA2 subtype have a functional
voltage dependence - intracellular polyamines can serve as channel blockers in the
AMPA receptor TMD. In AMPA receptors, this polyamine block occurs after the
membrane is depolarized, as opposed to the Mg2+ block in NMDA receptors, which is
released once the membrane is depolarized. NMDA receptors, like AMPA receptors,
are two-fold symmetric and can function without a proper ATD [12] and adopts a
"ballon-shape" conformation rather than the characteristic Y-shaped conformation
of GluA2 homomers.
1.2 Molecular Simulations of iGluRs
Computer simulations of the fundamental interactions required to model the behavior
of a system has a rich history. The first numerical simulations were performed by
Enrico Fermi, John Pasta, and Stanislaw Ulam in 1955 on a one-dimensional vibrating
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string of particles [13]. Aneesur Rahman published the first simulations of liquid argon
using a Lennard-Jones potential in 1964 [14]. Finally, the first molecular dynamics
simulations of a biological macromolecule was published by J. Andrew McCammon,
Bruce R. Gelin, and Martin Karplus in 1977 on the bovine pancreatic trypsin inhibitor
[15]. Today, molecular dynamics is a commonly used computational tool to probe the
behavior of chemical and biological systems.
Typically in a molecular dynamics simulation, Newton’s equations of motion:
𝐹 = −∇𝑈 are solved for every particle in the system under consideration. The algo-
rithm responsible for the numerical integration of the equations of motion is termed
the integrator. Special consideration should be paid to the interatomic potentials
or "force-fields" used as they often determine the range and accuracy of the phys-
ical phenomena to be studied. Furthermore, the size of the system determines the
computational cost of a particular simulation. Currently the most computationally
intensive task is the evaluation of pair-wise electrostatic interactions, which scales as
𝑂(𝑛2); although particle mesh Ewald algorithms reduce this to 𝑂(𝑛 log 𝑛).
Molecular simulations of iGluRs have proven useful in determining the properties
of these receptors. X-ray crystallographic analyses have shown that iGluR LBDs
adopt two distinct structural conformations, open in the apo form, and closed once
agonist is bound [16, 17]. MD simulations of the structural fluctuations of AMPA-
type iGluR LBDs spanning ∼2 ns demonstrated hints of domain closure motions in
the apo form in 2002 [18]. Electrostatic calculations of the apo LBD found that
molecular surface of the binding site contains a mostly positive electrostatic potential
which may attract negatively charged ligands [19]. The free energy of ligand binding
was calculated for several different agonists [20] as well as the free energy landscape
of domain closure motions [21, 22]. Furthermore, the LBD-TMD linkers couples the
useful work performed during domain closure to opening of the channel pore [23].
1.3 Central Objectives
The central objective of this dissertation is to understand the molecular processes gov-
erning iGluR behavior. Like other ion channels, iGluRs undergo both activation and
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densensitization. During activation, chemical stimuli in the form of glutamate binding
leads to the rapid conduction of ions. LBD domain closure and other conformational
rearrangements are proposed to play a role [24]; although the precise molecular mech-
anisms involved are still unclear. Desensitization occurs when further application of
stimuli results in submaximal or no current response from the receptor. In AMPA
receptors, desensitization involves conformational rearrangements which disrupt the
LBD dimer interface [25]. The molecular details of AMPA receptor densensitization,
however, are not well understood.
AMPA receptors activate within a few hundred 𝜇s and densensitize in ms whereas
NMDA receptors have slower kinetics [26]. The fast kinetics of AMPA receptors sug-
gest that AMPA receptor processes are particularly amenable to MD simulations.
NMDA receptor processes on the other hand, may require greater degrees of extrap-
olation or more focused simulations which examine the mechanisms piecemeal. The
content of this dissertation is focused on two molecular processes which occur during
iGluR activation - ligand binding, and LBD conformational change.
1.3.1 Aim 1: iGluR ligand binding
Crystal structures of the agonist bound AMPA-type LBD feature several protein-
ligand interactions in the binding pocket [17]. The glutamate ligand is orientated
with the 𝛼-carboxyl group pointing towards Lobe 1 of the LBD, anchored by a posi-
tively charged arginine residue (R485). Interactions between R485 and glutamate are
essential for binding - R485 is conserved across all glutamate receptor classes, and
mutations of the residue to lysine abolish binding in GluA1 and GluA4 LBDs [27,28].
The ligand’s amide group contacts a negatively, charged glutamate (E705) side chain
at the center of the binding pocket, and forms additional hydrogen-bonding interac-
tions with Thr 480 and Pro 478. The ligand’s 𝛾-carboxyl group is further secured by
interactions with the amide backbones of Ser 654 and Thr 655 on Lobe 2 of the LBD.
Prior to our studies, time-resolved fourier-transform infrared spectroscopy (FTIR)
experiments suggested that glutamate binds through a two step mechanism involving
first, establishment of 𝛼-carboxyl interactions with Lobe 1 and secondly, domain clo-
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sure and formation of 𝛾-carboxyl interactions with residues on Lobe 2 of the LBD [29].
Despite much success in determining the free energies of ligand binding [20] and cap-
turing structural conformations of ligand bound states, little is known of the molecular
mechanisms by which the ligand finds its way into the binding pocket. Modelling this
process is one of the primary goals of this dissertation.
1.3.2 Aim 2: iGluR LBD conformational change
LBDs close in a clamshell-like motion in response to agonist binding. Crystallographic
structures of the glutamate bound and apo AMPA type LBDs have detected an ∼20o
difference between Lobe 1 and Lobe 2 of the LBD, as measured along an axis of
rotation parallel to the to the axis of helix I and perpendicular to the two interdomain
𝛽-strands. Free energy landscapes of AMPA-receptor domain closure motions have
previously been calculated and found to contribute substantially to the free energy of
ligand binding [20], demonstrating that much of the useful work performed by ligand
binding is directly translated into domain closure motions. The energetics of domain
closure motions have also been computed for other iGluR classes, including the NMDA
receptor [22]. However, several open questions remain regarding LBD conformational
change. How is ligand binding mechanistically coupled to domain closure? To what
degree can domain closure motions be tuned by specific interactions between Lobe 1
and Lobe 2? How does LBD domain closure induce pore opening? We attempt to
address the former two questions in this disseration, and leave the latter for future
studies.
1.4 Overview of remainder of thesis
The remainder of this thesis is motivated by the two aims above, and will be organized
as follows.
Chapter 2 provides a brief overview of molecular dynamics simulations, both
theory and implementation for one of the commonly used free energy methods used
in this thesis (e.g. umbrella sampling), and instructions on the application of free
energy methods to iGluRs.
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Chapter 3 explores the energetics of LBD conformational change of a particularly
high affinity glycine-binding domain, which is evolutionarily related to glycine binding
NMDA subunits (GluN1/GluN3). The theoretical free energy landscapes calculated
here provide the basis for understanding how a single interdomain interaction, between
an arginine on Lobe 1 and glutamate on Lobe 2, may tune the LBD binding affinity
by three orders of magnitude and densensitization kinetics of the receptor by two
orders of magnitude.
Chapter 4 presents the first simulations of ligand binding in an AMPA-type
iGluR LBD. Metastable interactions with positively charged residues on the surface
of the LBD are found to funnel the negatively charged ligand into the binding pocket.
3D free energy landscapes that calculate the energetics of transient binding sites for
the ligand are used to delineate the possible pathways with which the ligand may
bind. Electrophysiological recordings demonstrate that elimination of these transient
binding sites significantly affects the activation kinetics of the receptor.
Chapter 5 examines ligand binding in the AMPA-type iGluR LBD using a
"chain-of-states" technique, the string method, in which the ligand binding process
is split into individual transition states between the ligand bound and apo confor-
mations. This presents several computational advantages over brute force simulation
methods, including greater sampling of the transition event, which is particularly
useful if the transition event is rare, as in ligand binding. Multiple pathways for






Fig. 1-1: Full-length AMPA and NMDA receptors. The crystal structure
of the intact AMPA homomer (PDB ID: 3KG2), left panel. Subunits A, B, C, D
are shown in blue, red, green, and orange respectively. Subunit A is equivalent to
subunit C, whereas subunit B is equivalent to subunit D. The crystal structure of
the intact NMDA heterotetramer (PDB ID: 4TLL) composed of two GluN1 and two
GluN2B subunits, right panel. GluN1 subunits which bind glycine are shown in blue,
whereas GluN2B subunits which bind glutamate are shown in orange. Both AMPA
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Ionotropic glutamate receptors (iGluRs) transduce chemical signals at synapses
into electrical impulses. This function relies on concerted conformational changes that
are propagated among the linked domains of the tetrameric protein assembly making
up each receptor. A key conformational change is the closure of the ligand-binding
domain (LBD) upon agonist binding, which eventually gates the transmembrane ion
channel domain. The free energy that becomes available for gating transitions is gov-
erned by the LBD free energy landscapes for apo and ligand-bound states. These
landscapes describe the thermodynamic equilibrium among various LBD conforma-
tions. Delineating these landscapes is essential for understanding the molecular driv-
ing forces underlying iGluR function. Molecular dynamics free energy simulations
offer a means for estimating these quantities, which are difficult to extract from ex-
perimental results alone. Here, we describe the process of carrying out a free energy
computation using an umbrella sampling strategy for characterizing large-scale con-
formational changes in iGluR LBDs.
2.1 Background
Structural studies of ionotropic glutamate receptors (iGluRs) have provided valuable
insights into the molecular mechanics of activation and desensitization [1]. These
studies have helped characterize the conformational changes that take place within
an isolated ligand-binding domain (LBD) upon binding of agonists and antagonists
in addition to the molecular rearrangements that are associated with desensitization.
The numerous crystal structures of isolated iGluR domains and intact iGluR recep-
tors also provide atomistic models that enable molecular simulation studies. Such
studies allow one to probe conformational energetics not easily accessed by experi-
mental approaches alone by, for example, considering conformational states that are
transient, not heavily populated, or refractory to crystallization. Such considerations
are important for understanding iGluRs, which are allosteric receptors that rely on
complex molecular dynamics for executing their function.
Straightforward, unbiased molecular dynamics (MD) simulations have shed light
on important dynamic events involving the LBD; for example, by suggesting pos-
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sible pathways for conformational changes related to receptor activation [2, 3] and
rearrangements in the configuration of waters in the binding cleft [4]. While these
types of simulations are useful, they can have limitations when applied to complex
macromolecular systems that exhibit significant conformational changes. Instead,
one can employ a simulation strategy that generates a "free energy landscape", or
equivalently, a "potential of mean force" (PMF), along specifically chosen coordinates
to obtain a reduced description of conformational changes in the system. The free
energy difference between conformational states reflects the probability of finding the
system in those states.
This chapter focuses on the computation of free energy landscapes using umbrella
sampling MD simulations. The systems of interest here are iGluR LBDs. Due to
space constraints, we limit the discussion of numerous general aspects of setting up
and carrying out an MD simulation. These topics, however, are covered elsewhere
in excellent overviews, e.g., by Cheng and Ivanov [5] and the NAMD tutorials at
www.ks.uiuc.edu/Training/Tutorials/namd-index.html. The theory of umbrella sam-
pling is discussed in some detail for the sake of completeness and because of its
practical utility, as it provides a guide for writing the computer code necessary for
carrying out the calculations. We hope that this chapter will be useful to readers in
facilitating computational studies of iGluR conformational energetics.
2.2 Materials
The most widely used molecular dynamics (MD) simulation packages for biomolecules
are CHARMM [6], AMBER [7], GROMOS [8], NAMD [9], and GROMACS [10].
CHARMM and AMBER have been in continuous development for the longest, offer
advanced sampling and analysis capabilities, and are associated with their own force
fields for proteins, nucleic acids, lipids, and carbohydrates [5]. All LBD umbrella sam-
pling simulations described below were performed using CHARMM, although other
packages can be used as well. NAMD and GROMACS have been developed to excel
in performance (i.e., computational speed), and they support numerous force fields.
The package Desmond [11], from D.E. Shaw Research, also offers high performance
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and supports multiple force fields. For a comparison of different force fields, see a
review by Guvench and MacKerell [12]. VMD [13] is a widely used molecular graphics
program for structure and trajectory analysis.
MD packages generally require an operating system based on Unix/Linux. Some
aspects of setting up a simulation system may be accomplished on a workstation, but
equilibration and production simulations are typically performed on either commod-
ity computing clusters containing many processors or high-end computing platforms
available through resources such as the Extreme Science and Engineering Discovery
Environment (XSEDE; www.xsede.org).
2.3 Methods
2.3.1 Molecular Dynamics Simulations
At the heart of a molecular mechanics simulation is the potential energy function
that relates the atomic coordinates of a system, R, to the energy, 𝑈 [14] (Fig. 2-1).
































where the equilibrium values for the bond distance, b, the valence angle, 𝜃, and the
improper dihedral angle (out-of-plane distortion), 𝜒, are 𝑏0, 𝜃0, and 𝜒0, respectively;
the multiplicity and phase for the dihedral angle, 𝜑, are 𝑛 and 𝛿; 𝑞𝑖 and 𝑞𝑗 are the par-
tial atomic charges on atoms i and j; the Ks are the force constants; 𝜖 is the dielectric
constant; 𝑟𝑖𝑗 is the distance between atoms i and j; and the Lennard-Jones potential
well depth and minimum interaction radius are 𝜖𝑖𝑗 and 𝑅min,𝑖𝑗. The "bonded" terms
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are the bonds, angles, dihedrals, and improper dihedrals; the "nonbonded" terms are
the electrostatic interactions treated using a Coulombic term and the interatomic re-
pulsion and dispersion interactions treated using a Lennard-Jones "6-12" term. These
terms are common to most modern biomolecular force fields, including CHARMM,
AMBER, GROMOS, and OPLS [15], among others. To increase the accuracy of
force fields, additional or alternate energy terms have been incorporated. An ex-
ample of an additional term is the two-dimensional dihedral energy grid "correction
map" (CMAP) applied to protein backbone 𝜑 and 𝜓 angles in CHARMM [16]. Other
examples are described in a review by MacKerell [14]. Once 𝑈(R) is defined, the time
evolution of a system of atoms may be obtained by integrating Newton’s equations
of motion,
𝐹 (R(𝑡)) = −∇𝑈(R(𝑡)) = 𝑀R̈(𝑡) (2.2)
where 𝑡 is time, 𝐹 is the ensemble of forces on the atoms, ∇𝑈 is the gradient of the
potential, 𝑀 is the matrix that specifies the mass of every atom, and R̈ is the second
derivative of the atomic coordinates with respect to time. Combining Taylor series
expansions for R(𝑡+𝛿𝑡) and R(𝑡−𝛿𝑡) yield the Verlet integration algorithm, which is
used to generate the dynamical trajectory of the system. Details concerning the prop-
agation of atomic velocities and positions, as well as many practical considerations
regarding MD simulations, are covered in a review by Cheng and Ivanov [5].
2.3.2 Order Parameters
How might one go about computing the change in free energy for a conformational
transition in a system? A first step would be to identify a continuous coordinate 𝜉,
also referred to as an order parameter, which is a function of a few or more degrees of
freedom in the system, and traverses the system’s conformational states of interest.
Order parameters along the most important degrees of freedom are often chosen as
a reduced descriptor of the system. Any choice of order parameter is possible, such
as a distance, an angle, or a root mean square deviation from a reference state. The
order parameter may be multidimensional, e.g., two distances or a distance plus an
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angle. Choosing an appropriate order parameter for a given system often requires a
mix of physical intuition and prior knowledge of the chemical process under consider-
ation. Several novel strategies have been developed to quantitatively determine order
parameters [17]. These techniques include combining MD simulations with either
principal component analysis (PCA) or a determination of the atomic fluctuations
that correspond to the largest amounts of information transfer in a conformational
transition. Normal mode analysis (NMA) has also been suggested as a means for
identifying the most important collective motions [18–20].
2.3.3 Umbrella Sampling
Once the order parameter, 𝜉, is chosen, the average distribution function along 𝜉 can






where 𝑈(R) is the energy of the system as a function of the atomic coordinates
R, 𝛿[·] is the Dirac delta function, 𝑘𝐵 is Boltzmann’s constant, and 𝑇 is temperature.
The free energy, or PMF, 𝑊 (𝜉), along 𝜉 can be computed as follows:





where 𝜉* is an arbitrary reference value. In principle, 𝑊 (𝜉) could be computed di-
rectly from a "brute force" molecular dynamics simulation of the system. In practice,
however, this approach is often limited because large free energy barriers along 𝜉 can
impede the amount of conformational space that is sampled within an allotted sim-
ulation time (Fig. 2-2). Poor sampling would yield unreliable statistics from which
to calculate free energy differences. Consequently, numerous sampling strategies have
been developed to more effectively calculate a PMF from molecular dynamics simula-
tion trajectories. One of these strategies is the umbrella sampling method developed
by Torrie and Valleau [23]. This method typically involves carrying out multiple inde-
pendent simulations, where each simulation takes place in the presence of an applied
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potential, 𝑤(𝜉). This artificial bias for each simulation, or window, confines sampling
to a region near a chosen value of 𝜉. The chosen 𝜉 is different for each window. A




𝐾(𝜉−𝜉𝑖)2, where K is the force constant. The set of 𝜉𝑖 spans the conformational
space of interest.




where ⟨𝜌(𝜉)⟩ is given by 2.3. The unbiased PMF from the 𝑖th window is
𝑊𝑖(𝜉) = 𝑊 (𝜉




− 𝑤𝑖(𝜉) + 𝐹𝑖 (2.6)
where 𝐹𝑖 is the free energy associated with introducing the window potential,
𝑤𝑖(𝜉),
𝑒−𝐹𝑖/𝑘𝐵𝑇 = ⟨𝑒−𝑤𝑖(𝜉)/𝑘𝐵𝑇 ⟩ (2.7)
The process of unbiasing and recombining the results of sampling in all the win-
dows in order to obtain 𝑊 (𝜉) involves calculating 𝐹𝑖. Numerous approaches have
been developed to accomplish this task [21–24]. We will discuss only one of these ap-
proaches, the weighted histogram analysis method (WHAM) [25], although other valid
approaches are available. Essentially, the WHAM estimates the unbiased distribution
function by computing a weighted sum of all the sampling data and determining the
functional form of the weight factors that minimizes the statistical error [21]. Given












where [⟨𝜌(𝜉)⟩](𝑖),unbiased are the individual unbiased distribution functions, and 𝑛𝑖
are the number of sampling data points used to generate each biased distribution
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function. Using 2.5 and 2.7,
[⟨𝜌(𝜉)⟩](𝑖),unbiased = ⟨𝜌(𝜉)⟩(𝑖) 𝑒𝑤𝑖(𝜉)/𝑘𝐵𝑇 𝑒−𝐹𝑖/𝑘𝐵𝑇 (2.9)

















2.10 and 2.11, known as the WHAM equations, are interdependent (i.e., 2.10
requires 𝐹𝑗, and 2.11 requires ⟨𝜌(𝜉)⟩) and are therefore solved in a self-consistent
manner via an iterative procedure. First, an estimate for the unbiased distribution
⟨𝜌(𝜉)⟩ is obtained using 2.10 and an initial guess for all of the 𝐹𝑗. Next, 2.11 is
evaluated using the estimate for ⟨𝜌(𝜉)⟩. The cycle is repeated using the new estimates
for 𝐹𝑗 until both equations have converged. The equations above are written in terms
of a one-dimensional 𝜉. The approach can be applied to multidimensional scenarios
as well. For example, 2.10 and 2.11 can be reformulated as follows for handling a
















Additional theoretical details and derivations may be found in Souaille and Roux
[28]. Generic computer code for carrying out WHAM calculations is also provided in
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this reference. The first PMFs computed for an iGluR LBD involved the GluA2 S1S2
construct [29]. The umbrella sampling simulations generating the PMFs employed
a two-dimensional order parameter consisting of two distances between the lobes of
the LBD (Fig. 2-3). The order parameter was inspired by the observation that the
distances between T480 and S654, and between E402 and T686 each differ by ∼3.5
Å when comparing crystal structures of apo and agonist-bound LBDs [30]. Each pair
of residues is hydrogen bonded in the agonist-bound structures but not in the apo
structure. In the order parameter (𝜉1, 𝜉2), 𝜉1 is the distance between the centers of
mass (COM) of residues 479-481 in lobe 1 and residues 654-655 in lobe 2, and 𝜉2 is
the distance between the COM of residues 401-403 in lobe 1 and residues 686-687
in lobe 2. These residues correspond to regions that are not in flexible loops. All
non-hydrogen atoms were included in the selections. The rationale for using multiple
residues in the definitions of 𝜉1 and 𝜉2 was to increase the likelihood that changes in
the COM distances would represent large-scale conformational changes rather than
fluctuations in individual residues. We should note that we initially attempted to
define an angle to monitor opening and closing of the LBD, in a fashion similar to
how the crystal structures were characterized. However, we found this choice of order
parameter too unwieldy for use with the umbrella sampling restraining potentials.
Other order parameters have been used by other investigators, for example, the dis-
tance between the C𝛼 atoms of G451 and S652 [31]. Our chosen order parameter was
intended to sufficiently capture the principal conformational transition inferred from
LBD crystal structures. We acknowledge, however, that an order parameter with
higher dimensionality would be required to capture motions involving additional de-
grees of freedom.
In our previous studies [29, 32, 33], we have found that umbrella sampling win-
dows spaced 1 Å apart along 𝜉1 and 𝜉2 provide sufficient sampling overlap between
neighboring windows. Windows spanning (𝜉1, 𝜉2) = (8, 6) to (18,17) (in Å) appear to
provide reasonable coverage of conformational space (Fig. 2-4). Initially, for GluA2,
∼200 windows were used [29]. Many of these windows, however, turned out to reside
in regions of high conformational free energy. Subsequently, for GluN1, GluN2A,
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and GluN3A, the number of windows was cut to the ∼100 that contribute most to
⟨𝜌(𝜉1, 𝜉2)⟩ [33]. Windows in the "corner" regions, which correspond to either large 𝜉1
and small 𝜉2 or small 𝜉1 and large 𝜉2, are the windows that are generally very high in
conformational free energy and can be safely omitted from the computation.
2.3.4 Setting Up the System
Molecular simulations require complete protein models; that is, any missing non-
hydrogen side chain or backbone atoms in a PDB entry must be built into the model.
For building missing sidechains, we routinely use the program SCWRL [34]. For
building missing backbone atoms, we use the loop-modeling routine of the program
MODELER [35], also available via the ModLoop server (modbase.compbio.ucsf.edu).
The next task is to generate initial protein configurations for each of the umbrella
sampling windows. We use a targeted (biased potential) MD procedure to generate
these LBD configurations. In this procedure, the C𝛼 atoms of lobes 1 and 2 are sep-
arately restrained to their crystal structure configuration using an RMSD restraining
potential while the lobes are pushed apart by performing dynamics in the presence
of biasing potentials applied separately to 𝜉1 and 𝜉2. These simulations are run in
vacuum. The intent of the RMSD restraints is to prevent the lobes from partially
unfolding while 𝜉1 and 𝜉2 are rapidly moved apart. First, 𝜉1 and 𝜉2 are simultane-
ously incremented starting from a closed-conformation crystal structure. Next, 𝜉1
and 𝜉2 are individually incremented starting from configurations generated in the
previous step. System setup concludes with solvating each conformer with explicit
water and 100-150 mM NaCl. Nonzero total charge on the protein (and ligand, if
present) may be neutralized by using excess Na+ or Cl− ions. We retain the positions
of crystallographically-determined water molecules within the binding cleft.
2.3.5 Small Molecule Parametrization
For iGluR ligands (small organic molecules) that are not amino acids, the molecular
mechanics parameters and charges will need to be determined. This can be accom-
plished a number of ways. One approach is to use the general AMBER force field
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(GAFF) [36] together with Antechamber, a toolkit for automatic atom typing [37].
For CHARMM-consistent parameters, the CHARMM general force field (CGenFF)
program can be used for automatic atom typing and assignment of parameters and
charges by analogy [38,39]. Alternatively, a method called general automated atomic
model parameterization (GAAMP) can be used to generate parameters based on
the results of ab initio quantum mechanical (QM) calculations [40]. GAAMP can
also be used to optimize existing parameter sets. Two web portals are available
for automatic parameterization of small compounds using CGenFF: ParamChem
(www.paramchem.org) and MATCH (brooks.chem.lsa.umich.edu/index.php?matchserver=submit).
A web portal for GAAMP is at gaamp.lcrc.anl.gov. Finally, parameterization can be
performed manually. Our approach for DNQX [29] included the following steps: (1)
charge fit a geometry-optimized molecule to QM electrostatic potential maps, (2)
optimize force constants by reproducing vibrational frequencies and potential energy
distributions from QM calculations, and (3) optimize dihedral angle parameters by
reproducing dihedral potential energy surfaces from QM calculations.
2.3.6 Equilibriation and Production
Each system must be equilibrated before sampling data are collected. The steps we
routinely take are described below:
- First, the protein and ligand atoms are held fixed while dynamics are carried out
on the solvent.
- Next, dynamics are carried out in the presence of stabilizing restraining potentials
on the protein and ligand. These restraints are gradually reduced over the course
of the equilibration, which is carried out in the constant atom number, volume, and
temperature (NVT) ensemble.
- Finally, after these restraints have been removed, the simulation is transitioned to
a constant pressure (NPT) ensemble.
In all steps of the equilibration involving non-fixed protein and ligand atoms, the
umbrella restraints on 𝜉1 and 𝜉2 are also applied, as well as weak restraints on the
COM of three regions in the core of lobe 1. The latter restraint, which does not
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hinder inter-lobe dynamics, prevents translation and rotation of the protein during
the production phase of the simulations.
The most effective way to implement the restraints described above vary depend-
ing on which MD simulation package is used. For example, in CHARMM, we use the
restraint invoked by the keywords "CONS HARM" for the stabilizing potential. The
"MMFP GEO SPHERE RCM DISTANCE" restraint is used for 𝜉1 and 𝜉2, and the
"CONS HMCM" restraint is used for translation/rotation. The "MMFP" module
allows the instantaneous values of 𝜉1 and 𝜉2 to be written on-the-fly. Details speci-
fying how to use these keywords are included in CHARMM’s "doc" (documentation)
directory.
The simulations enter production phase after equilibration has completed. Here,
the values for 𝜉1 and 𝜉2 in each window 𝑖 are recorded, which contribute to the biased
distribution function ⟨𝜌(𝜉1, 𝜉2)⟩(𝑖) (see 2.5). It is critical that all distributions are care-
fully monitored to make sure there is sufficient overlap between neighboring windows,
which is a requirement of WHAM [24]. If deficiencies are observed, additional win-
dows at intermediate positions may be added. Additional windows may also be added
to expand the boundaries of (𝜉1, 𝜉2) if, after computing 𝑊 (𝜉1, 𝜉2), it is determined
that the free energy basins have not been sufficiently mapped. Automated adaptive
umbrella sampling approaches may also be useful for optimizing the task of selecting
windows [41].
2.3.7 Error Analysis
Once 𝑊 (𝜉1, 𝜉2) has been computed, the quality of the sampling can be assessed. Two
methods of analysis are block averaging and bootstrapping. In block averaging, as
the name suggests, the sampling data (e.g., (𝜉1, 𝜉2)) are divided into 𝑀 segments, or
"blocks", corresponding to a given simulation time. The PMF is then calculated for
each block, and error bars can be generated to represent the deviation observed in
the 𝑀 PMFs. For a recent example of block averaging applied to umbrella sampling,
see Park et al. [42]. In bootstrapping [43], "resampled" data sets are constructed by
randomly selecting data points from the original sampling data. The resampling takes
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place using time intervals estimated to correspond to the time it takes for correlated
fluctuations in (𝜉1, 𝜉2) to decay to zero. Previously, we used time intervals of 300 ps
for GluN LBDs and 200 ps for the GluA2 LBD [33]. Resampling is repeated until
each resampled data set is the same size as the original. The PMF is then calculated
for each resampled set, and error bars can be generated as described above.
Ensuring that convergence in the sampling has been reached, using, for exam-
ple, one or both of the methods described above, is an important step in molecular
simulation studies. It is also a prerequisite for reasonably comparing the computed
free energies with experimental measurements. For the computations described in
this chapter, which are focused on large-scale conformational transitions, experimen-
tal measurements that, at least in principle, can be compared fairly directly include
those that characterize conformational ensembles in solution, such as small-angle
X-ray scattering (SAXS) [29, 44], and nuclear magnetic resonance (NMR) [45] and
fluorescence resonance energy transfer (FRET) spectroscopy [46]. The computed free
energy landscapes provide Boltzmann weights to be applied to the molecular config-
urations extracted from the simulations, which in turn provide a framework, based
on molecular ensembles, for interpreting the measured data.
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Fig. 2-1: A molecular mechanics potential energy function typically includes
terms describing bond stretching (𝑏), bond angle bending (𝜃), bond twsiting (𝜑),
out-of-plane distortions (𝜒, and non-bonded interactions (𝑟).
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Fig. 2-2: Free energy barriers. In unbiased molecular simulations, one or more
large free energy barries along an order parameter, 𝜉, can impede conformational
sampling (depicted in red).
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Fig. 2-3: Order parameters. Our chosen order parameter, (𝜉1, 𝜉2), used to de-
scribe large-scale conformational transitions in the GluA2 LBD. 𝜉1 and 𝜉2 indicate
the distances between the centers of mass of the atoms that are shown as spheres. In
this figure, (𝜉1, 𝜉2) = ( 12.8 Å, 11.4 Å)
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Fig. 2-4: Umbrella sampling involving the GluN1 glycine-bound LBD. The top
panel shows the umbrella restraining potential equilibrium positions of the 93 windows
that produce the free energy landscape shown in the bottom panel. In the bottom
panel, each contour level corresponds to a difference of 1 kcal/mol, and darker regions
are lower in free energy. See Yao et al. [33] for details.
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Glycine-activated ionotropic glutamate receptors (iGluRs) encoded in ctenophore
genomes are evolutionary precursors to NMDA receptors, which play important roles
in synaptic plasticity. Ctenophore iGluRs feature a distinct interdomain salt bridge
in the ligand-binding domain, a molecular lock, thus far not found in iGluRs of other
organisms. We use a combination of crystallographic, biochemical, electrophysiolog-
ical, and computational approaches to elucidate the role of this molecular lock in a
ctenophore iGluR. We find that perturbations to the lock can tune receptor kinetics
and thermodynamics over very broad ranges. We also find that the strategic location
of the lock may be the basis for the ligand-binding domain’s extraordinarily high
affinity for glycine.
The earliest metazoan ancestors of humans include the ctenophore Mnemiopsis
leidyi. The genome of this comb jelly encodes homologs of vertebrate ionotropic
glutamate receptors (iGluRs) that are distantly related to glycine-activated NMDA
receptors and that bind glycine with unusually high affinity. Using ligand-binding do-
main (LBD) mutants for electrophysiological analysis, we demonstrate that perturb-
ing a ctenophore-specific interdomain Arg-Glu salt bridge that is notably absent from
vertebrate AMPA, kainate, and NMDA iGluRs greatly increases the rate of recovery
from desensitization, while biochemical analysis reveals a large decrease in affinity for
glycine. X-ray crystallographic analysis details rearrangements in the binding pocket
stemming from the mutations, and molecular dynamics simulations suggest that the
interdomain salt bridge acts as a steric barrier regulating ligand binding and that
the free energy required to access open conformations in the glycine-bound LBD is
largely responsible for differences in ligand affinity among the LBD variants.
3.1 Background
Glutamate receptor ion channels (iGluRs) are membrane proteins that mediate ex-
citatory synaptic transmission in the brain by detecting release of the amino acid
glutamate from nerve terminals [1]. In combination with GluN2 subunits, which bind
glutamate, NMDA subtype iGluRs use glycine as a coagonist, which binds to GluN1,
GluN3A, and GluN3B subunits [2–6]. NMDA receptors play key roles in synaptic
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plasticity and memory formation, and mutations of NMDA receptor genes underlie
a diverse set of neurological and psychiatric diseases [7]. Like all iGluRs, NMDA
receptors are assembled from modular subunits containing amino terminal and S1S2
ligand binding domains (LBDs), which can be genetically isolated and expressed as
soluble proteins for biochemical and structural analysis [4, 8–10]. The LBDs of both
the glutamate and glycine binding subunits are clamshell-shaped proteins of molec-
ular mass around 30 kDa in which two lobes are connected by a hinge formed by
antiparallel 𝛽-strands; in the activated state, ligands are trapped in a cavity formed
when the clamshell closes. Strikingly, the volume of the ligand binding cavity for the
GluN1, GluN3A, and GluN3B subunits is just large enough to accommodate glycine,
whereas iGluR glutamate binding subunits have cavities that are four to five times
larger and bind both glutamate and up to six or seven water molecules [4, 10–13].
We recently reported the discovery of glycine-activated iGluRs from the comb jelly
Mnemiopsis leidyi and the sea gooseberry Pleurobrachia bachei, candidates for earli-
est lineage metazoans, for which ML032222a and PbGluR3 glycine complex crystal
structures reveal a salt bridge at the perimeter of the ligand binding cleft [14]. This
salt bridge links the upper and lower lobes of the LBD in the closed cleft glycine-bound
conformation. Ctenophore iGluR subunits bind glycine with such high affinity that
the ligand cannot be removed by exhaustive dialysis, suggesting an unusually stable
ligand-bound closed-cleft conformation, perhaps stabilized by the interdomain salt
bridge. Prior electrophysiological and crystallographic studies on vertebrate AMPA
and kainate subtype iGluRs revealed that the stability of the closed cleft conformation
is determined not only by contacts of the LBD with the neurotransmitter ligand but
also by contacts formed between the upper and lower lobes of the clamshell assembly
that occur only in the ligand-bound closed-cleft conformation [15, 16]. Comparison
of crystal structures of ctenophore iGluR LBDs with those of vertebrate NMDA re-
ceptor GluN1 and GluN3 subunits that also bind glycine, but for which apo proteins
can be prepared without difficulty [4, 10], reveals that the salt bridge is unique to
ctenophore iGluRs, further suggesting that it might underlie the high stability of the
glycine complex.
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To investigate this, we prepared ML032222a mutant proteins and analyzed their
ligand binding properties using electrophysiological, biochemical, and crystallographic
techniques. To gain further insight into how these mutants perturb large-scale LBD
dynamics, we computed conformational free energy landscapes for the apo state and
glycine complexes of wild-type (WT) ML032222a and the R703K and E423S mutants,
which weaken and break the interdomain salt bridge, respectively. This analysis
reveals that, similar to vertebrate GluN1 and GluN3 glycine binding subunits, the
apo state for ML032222a can access closed cleft conformations, although it is more
stable in slightly open conformations. The R703K and E423S mutants destabilize
closed cleft conformations for the glycine complex. Conformational dynamics inferred
from the free energy landscapes suggest that the interdomain salt bridge is positioned
at the most likely point of ligand entry to (and exit from) the binding pocket and
thus acts as a steric barrier regulating the binding and dissociation of glycine
3.2 Results
3.2.1 Interdomain Salt Bridge Mutants Regulate Recovery
from Desensitization.
ML032222a from the comb jelly M. leidyi forms a homomeric glycine-activated ion
channel with rapid onset but extremely slow recovery from desensitization [14]. We
hypothesized that the unusually slow recovery from desensitization for ML032222a,
which lasts for several minutes, occurs because the glycine bound LBD is trapped in
a closed cleft conformation by a lock at the entrance to the binding site (Fig. 3-1A)
and that the receptor cannot recover from desensitization until the clamshell opens
and glycine dissociates. In the ML032222a LBD crystal structure, this lock is formed
by an interdomain salt bridge between Glu423 in lobe 1 and Arg703 in lobe 2 (Fig. 3-
1B). To weaken this interaction we prepared two mutants, ML032222a R703K and
ML032222a E423S, and expressed them in Xenopus oocytes for electrophysiological
analysis. Twin pulse applications of glycine for WT ML032222a revealed that recovery
from desensitization required several minutes (Fig. 3-1C), with progressively faster
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recovery for the R703K (Fig. 3-1D) and E423S mutants (Fig. 3-1E); when fit with
exponential functions, the rate constant for recovery from desensitization increased
4-fold for the R703K mutant and 61-fold for the E423S mutant (Fig. 3-1F) [rate
constant: 0.016 ± 0.003 s−1 for WT (𝑛 = 4), 0.061 ± 0.003 s−1 for R703K (𝑛 = 3),
and 0.96 ± 0.06 s−1 for E423S (𝑛 = 3)].
3.2.2 Interdomain Salt Bridge Mutants Lower Affinity for
Glycine.
The S1S2 LBD of ML032222a expressed as a soluble protein binds glycine with an
affinity of 2.3 nM and is resistant to proteolysis by trypsin unless it is dialyzed in
the unfolded state to remove endogenous glycine that remains bound during purifi-
cation [14]. Proteolysis protection assays revealed that similar to the WT protein,
unfolding and dialysis in 4 M guanadinium was also required to prepare apo pro-
tein for the R703K mutant, whereas by contrast, for the E423S mutant, apo protein
could be prepared by exhaustive dialysis without the need for unfolding (Fig. 3-2A).
Similar to WT ML032222a, both mutants became resistant to digestion by trypsin
following addition of glycine to the refolded apo protein, indicating that they remain
competent to bind glycine (Fig. 3-2A), consistent with the results of electrophysio-
logical experiments that show activation of ion channel gating by glycine (Fig. 3-1).
Using refolded or dialyzed proteins as appropriate, we then performed isothermal
titration calorimetry (ITC) to measure the thermodynamics of ligand binding. In
previously published work, we obtained a 𝐾𝑑 of 2.7 nM (95% CI: 1.03, 4.95 nM) for
WT ML032222a; binding was strongly exothermic (∆G, -11.50 kcal/mol; ∆H, -17.34
kcal/mol; T∆S, -5.84 kcal/mol) [14]. For the R703K mutant, the 𝐾𝑑 increased 10-
fold to 28.3 nM (95% CI: 19.1, 40.9 nM); binding remained exothermic (∆G, -10.12
kcal/mol; ∆H, -21.13 kcal/mol; T∆S, -11.01 kcal/mol) (Fig. 3-2B). For the E423S
mutant, the 𝐾𝑑 increased nearly three orders of magnitude to 2.48 𝜇M (95% CI: 2.16,
2.84 𝜇M); binding remained exothermic (∆G, -7.52 kcal/mol; ∆H, -18.11 kcal/mol;
T∆S, -10.59 kcal/mol) (Fig. 3-2C). These results suggest that faster recovery from
desensitization for the mutant proteins observed in electrophysiological experiments
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(Fig. 3-1) is a direct consequence of disrupting the interdomain salt bridge lock.
3.2.3 Crystal Structures of Interdomain Salt Bridge Mutants.
In the presence of glycine, the R703K and E423S mutant S1S2 LBDs crystallized as
dimer assemblies in the same space group as the WT protein and diffracted X-rays
to Bragg spacings of 1.34 and 1.28 Å, respectively (Table 3.1); electron density was
well resolved for the mutant side chains, the glycine ligand, and the numerous solvent
molecules flanking the binding site (Fig. 3-3). Least squares superpositions using 203
C𝛼 atom coordinates for the R703K and E423S mutants revealed essentially identical
conformations to the WT protein (RMSD, 0.26 and 0.20 Å, respectively). In all three
structures, glycine binds in a cavity, the sides and top of which are formed by the
apposed surfaces of lobes 1 and 2. In the R703K and E423S mutants the bound
glycine ligand forms the same series of contacts as occurs in the WT protein; the
glycine ligand 𝛼-carboxyl group is bound by the main chain amide of Ser499 and the
side chain of Arg504 in lobe 1 and by the main chain amide nitrogen of His505 in lobe
2; the glycine 𝛼-amino group is bound by the main chain carbonyl oxygen of Asp497
and the side chain hydroxyl group of Ser499 in lobe 1 and by the side chain of Glu747
in lobe 2 (Fig. 3-3).
Calculation of solvent accessible cavity volumes, with a probe radius of 1.4 Å, gave
similar values for WT ML032222a and for the R703K and E423S mutants (58.8 ± 0.01,
56.6 ± 0.1, and 59.0 ± 0.03 Å3, respectively; mean ± SEM; 𝑛 = 3); however, close
inspection of the cavity volumes revealed subtle changes in shape due to movements
resulting from introduction of the mutant side chains (Fig. 3-4). As a result, in lobe
2, the binding site surfaces for the mutant structures are distinct from those for WT
ML032222a (Fig. 3-3A). In the R703K mutant, the side chain of Glu423 rotates 43∘
around Chi2 and 31∘ around Chi3 such that the Glu OE2 carboxyl group oxygen
atom moves 1.8 Å away from the glycine ligand to form an ion pair contact with the
R703K mutant side chain, breaking the carboxylate-carboxylate contact with Asp497
found in the WT structure (Fig. 3-3B). This movement creates a bulge occupied by
a water molecule (W9), which is coordinated by the Glu423, Asp497, and Glu747
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side chains (Fig. 3-3B). In the E423S mutant (Fig. 3-3C), a pair of water molecules
equivalent to W7 and W8 in the WT structure moves down toward the glycine ligand
such that W7 is positioned exactly at the location of the Glu423 OE1 carboxyl group
oxygen atom in the WT protein and makes hydrogen bond contacts with the mutant
Ser423, Asp497, and Arg703 side chains (Fig. 3-3C).
3.2.4 Conformational Dynamics of the LBD.
To gain further insight into the structural thermodynamics of the ML032222a LBD,
we computed the conformational free energy landscapes, or potentials of mean force
(PMFs), of the WT S1S2 LBD and the R703K and E423S mutants for both apo-
and glycine-bound forms. The PMFs were computed using umbrella sampling molec-
ular dynamics (MD) simulations in which a 2D order parameter (𝜉1, 𝜉2) was used
to characterize large-scale conformational changes in the LBD, where 𝜉1 and 𝜉2 are
center of mass distances between atom selections in lobes 1 and 2 (Fig. 3-5A). Um-
brella sampling using an analogous order parameter was used previously to character-
ize conformational transitions in AMPA and NMDA receptor LBDs, and the results
were found to be consistent with small-angle X-ray scattering (SAXS), ligand-binding
affinity, and single-molecule FRET (smFRET) studies [17–21]. Because in the crystal
structures the side chains of Glu423 and Asp497 are in close proximity, pKa calcu-
lations were carried out using PROPKA [22] to determine which protonation states
of these two residues to use in our simulations. On the basis of these calculations,
Glu423 was not protonated in the WT and R703K simulations, whereas Asp497 was
protonated. For the E423S LBD, the pKa calculations suggested that Asp497 should
not be protonated in the glycine complex but should be protonated in the apo state.
These protonation states were therefore used in the E423S simulations.
The WT apo LBD PMF features a broad free energy basin, indicating confor-
mational flexibility in the absence of ligands (Fig. 3-5B). The global free energy
minimum is located at (𝜉1, 𝜉2) = (10.7, 13.3 Å). As expected, the WT glycine-bound
LBD PMF features an energy basin that is narrower, indicating stabilized closed cleft
conformations. The global free energy minimum is located at (𝜉1, 𝜉2) = (9.0, 11.3
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Å). In the glycine complex crystal structure, the LBDs in the dimer assembly have
nearly identical conformations, which are located nearby at (𝜉1, 𝜉2) = (8.7, 10.7 Å)
and (8.7, 10.8 Å) for chains A and B, respectively. Although there is some overlap in
the free energy basins between the apo- and glycine-bound LBD PMFs, these LBDs
populate distinct conformational ensembles (Fig. 3-6). Within 1 kcal/mol of the min-
imum, the WT, apo LBD is able to access more open conformations, ranging from
(𝜉1, 𝜉2) = (9.8, 11 Å) to (𝜉1, 𝜉2) = (11.2, 14.2 Å), whereas the WT, glycine-bound
LBD occupies more closed conformations, from (𝜉1, 𝜉2) = (8.6, 10.3 Å) to (𝜉1, 𝜉2) =
(9.6, 11.1 Å). Interestingly, the apo ML032222a LBD exhibits a single conformational
free energy minimum, which is observed in glutamate-binding LBDs from the iGluRs
GluA2 and GluN2A rather than multiple conformational free energy minima, as seen
in glycine-binding LBDs from the iGluRs GluN1 and GluN3A [19].
For both the R703K and E423S mutants, the apo LBD PMFs exhibit slightly
narrowed free energy basins compared with the WT protein (Fig. 3-5 C and D),
although all three PMFs are fairly similar. The glycine-bound LBD PMFs, however,
exhibit shallower free energy funnels, indicating that open LBD conformations are
easier to access. For apo R703K, the global free energy minimum is located at (𝜉1,
𝜉2) = (10.5, 12.7 Å), and for apo E423S, it is located at (𝜉1, 𝜉2) = (10.1, 12.0 Å).
For glycine-bound R703K, the global free energy minimum is located at (𝜉1, 𝜉2) =
(9.4, 11.3 Å), and for glycine-bound E423S, it is located at (𝜉1, 𝜉2) = (9.3, 12.2 Å).
Perhaps due to crystal lattice packing effects, the structures of the R703K and E423S
mutant glycine complexes adopt slightly more closed conformations, (𝜉1, 𝜉2) = (8.8,
10.4 Å) and (8.7, 10.6 Å), and (𝜉1, 𝜉2) = (8.7, 10.6 Å) and (8.7, 10.7 Å), for chains
A and B, respectively. Fig. 3-7 shows the SDs for the 2D PMFs, as determined by
block averaging.
3.2.5 Stability of the Interdomain Salt Bridge.
How stable is the salt bridge formed by Glu423 with the Arg or Lys residue at position
703? To examine the structural stability of this salt bridge in the WT and R703K
mutant LBDs as a function of LBD conformation in our simulations, we plotted side
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chain distances between residues 703 and 423 vs. (𝜉1, 𝜉2) (Fig. 3-8 A and B and
Fig. 3-9 A and B). The statistics for the WT glycine complex and apo systems were
calculated using ∼180,000 observations (snapshots extracted from the simulations)
for each state. The statistics for each of the R703K systems were calculated using
∼190,000 observations. Average distances (and their SDs) were calculated between
the closest nitrogen and oxygen atoms in the side chains of either Arg703 or Lys703
and Glu423, respectively. The distribution of average distances is not dramatically
different between the apo LBD and the glycine complex for either the WT or R703K
LBD. Residues 703 and 423, however, tend to stay in closer proximity for the WT
LBD than for the R703K variant, reflecting, unsurprisingly, a stronger interaction for
an arginine-glutamate pair than for a lysine-glutamate pair. The SDs of the average
distances, however, are greater in the WT LBD, especially for the glycine complex,
than for the R703K LBD. These results indicate that the Arg703-Glu423 bridge is
able to remain intact over a larger range of LBD conformations than the Lys703-
Glu423 bridge. The regions of large fluctuations in the Arg703-Glu423 distance, i.e.,
the SDs, indicate LBD conformations for which this salt bridge is strained.
The rotation of the Glu423 side chain away from Asp497 observed in the crystal
structure of the R703K glycine complex LBD is also seen in the simulations of both
WT and R703K proteins. Interestingly, this rotation occurs much more in the apo
LBDs than in the glycine complexes (Fig. 3-8 C and D and Fig. 3-9 C and D).
Although the bound glycine ligand does not directly contact Glu423, the ligand may
stabilize the binding pocket residues in such a way that disfavors rotation of Glu423
out of the pocket. It is also possible that the orientation of Glu423 could impact
stability of the Arg/Lys703-Glu423 salt bridge. If so, this would imply that the
salt bridge "locks" apo and glycine-bound LBDs to different extents. The similarity
in the PMFs for the apo WT, R703K, and E423S LBDs suggests the salt bridge
conformationally restricts the glycine-bound LBD more than the apo state.
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3.2.6 Occupancy of Binding Pocket Waters W9 and W7.
Specific water molecules in the binding pocket of the crystal structures for the R703K
and E423S LBDs, i.e., waters W9 and W7, respectively, have been described above.
How stable is the positioning of these waters, and what role might they play in stabi-
lizing these structures? To examine water stability as a function of LBD conformation
in our simulations, we plotted average occupancies of the water coordination sites vs.
(𝜉1, 𝜉2) (Fig. 3-10). For the R703K LBD, W9 is coordinated by the side chains of
Glu423, Asp497, and Glu747. For the E423S LBD, W7 is coordinated by the side
chains of Ser423, Asp497, and Arg703. In our simulation trajectories, a coordination
site is considered occupied if a water’s oxygen atom is within 3.2 Å of a nitrogen or
oxygen atom belonging to each of the three coordinating side chains. For the R703K
LBD, W9 is coordinated with high probability in certain closed-cleft conformations,
especially (𝜉1, 𝜉2) ∼ (11.5, 10.5 Å) for the apo state and (𝜉1, 𝜉2) ∼ (10.0, 9.0 Å) for the
glycine complex. For the E423S LBD, W7 is coordinated with high probability in a
subset of closed-cleft conformations for the glycine complex, but it is coordinated with
very low probability in the apo state in any conformation. The water occupancies for
the glycine complex simulations are consistent with the observation of bound waters
W7 and W9 observed in the crystal structures (see the locations of the crystal struc-
tures in Fig. 3-5 C and D). The computed water occupancies also reveal other LBD
conformations that give rise to side chain arrangements favorable to the coordination
of W9 and W7, suggesting an important role in the ligand-binding mechanism. The
statistics for each of the R703K systems and the apo E423S system were calculated
using ∼190,000 observations (snapshots extracted from the simulations); the statistics
for the glycine-bound E423S system were calculated using ∼132,000 observations.
3.2.7 The Conformational Free Energy Associated with Lig-
and Binding.
The total free energy of ligand binding into an LBD can be broadly decomposed into
free energy contributions resulting from ligand docking into the binding pocket and
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contributions resulting from large-scale LBD conformational changes, i.e., domain
closure [18]. To compute the LBD conformational free energy associated with glycine
binding, the extent to which the LBD has to open to allow glycine entry (and exit)
must first be determined. Access tunnels into the binding pocket were analyzed
using CAVER Analyst [23] for a selection of LBD conformations extracted from our
simulations (Fig. 3-11A). The residues forming the bottleneck for the passage of a
glycine molecule, which was estimated to have a minimum van der Waals radius of
2.62 Å, are Phe469 in lobe 1 and Arg/Lys703 in lobe 2, with Glu/Ser423 (in lobe
1) also lining the passageway. The minimum distance between the side chains of
residues 469 and 703 that allows glycine passage is ∼10 Å, as measured between
C𝛾 atoms. To examine glycine accessibility as a function of LBD conformation, we
plotted average distances (and their SDs) between residues 469 and 703 vs. (𝜉1, 𝜉2)
(Fig. 3-11 B-D and Fig. 3-12 A-C). Statistics for the WT glycine complex and
apo systems were calculated using ∼180,000 observations (snapshots extracted from
the simulations) for each state, ∼190,000 observations for the R703K systems, and
∼132,000 and ∼190,000 observations for the E423S glycine complex and apo systems,
respectively.
The relative probability for the LBD to adopt open conformations (allows glycine





Open exp(−𝑊 (𝜉1, 𝜉2/𝑘𝐵𝑇 ))𝑑𝜉1𝑑𝜉2∫︀
Closed exp(−𝑊 (𝜉1, 𝜉2/𝑘𝐵𝑇 ))𝑑𝜉1𝑑𝜉2
(3.1)
where Ω is the partition function for the LBD’s conformational state, Open indicates
the region of integration in the PMF, written as 𝑊 (𝜉1, 𝜉2), that corresponds to values
of (𝜉1, 𝜉2) in which the average distance between residues 469 and 703 ≥ 10 Å;
Closed indicates all other regions in the PMF; 𝑘𝐵 is Boltzmann’s constant, and 𝑇 is
temperature. The equation above can be related to the free energy difference between
the open and closed state ensembles as follows:







Finally, the difference in ∆𝐺conf between glycine-bound and apo LBDs is given by
∆∆𝐺conf = ∆𝐺conf,Gly − ∆𝐺conf,Apo (3.3)
∆∆𝐺conf represents the difference in conformational free energy between the glycine-
bound and apo LBDs for adopting open vs. closed states. In other words, ∆∆𝐺conf
is the conformational free energy gained by the system on glycine binding for ac-
cessing open states. It is important to note that ∆∆𝐺conf does not correspond to
the total binding free energy because free energy contributions associated with, for
example, translation of the ligand from bulk solvent into the binding site have not
been taken into account in this calculation. ∆∆𝐺conf alone, therefore, cannot be
directly compared with experimentally measured binding free energies. If the dif-
ferences in glycine binding affinity among the WT, R703K, and E423S proteins are
dominated by changes in LBD conformational free energies, however, then the trend
in calculated ∆∆𝐺conf values should follow the measured affinities. ∆𝐺conf were
computed for each PMF, using an integration region of {𝜉1 ≥ 12 Å and 𝜉2 ≥ 12
Å} for open conformations. The results are provided in Table 3.2. The trend
∆∆𝐺conf,WT > ∆∆𝐺conf,R703K > ∆∆𝐺conf,E423S is consistent with the measured affini-
ties, although (∆∆𝐺conf,WT − ∆∆𝐺conf,R703K) is larger than expected from the mea-
sured affinities and (∆∆𝐺conf,R703K − ∆∆𝐺conf,E423S) is smaller. These discrepancies
might be due to possible electrostatic interactions between the glycine ligand and
residues 703 and/or 423, which were not examined in this study. Varying the region
of integration by ±1 Å in either 𝜉1 or 𝜉2 does not change the trend or the ∆∆𝐺
values significantly. ∆𝐺conf,Apo is ∼3 kcal/mol for all three proteins, so ∆𝐺conf,Gly
therefore appears to be driving the changes in glycine affinity for the LBD variants;
the presence of glycine in the binding pocket makes it more difficult for the WT LBD
to adopt open conformations compared with the mutants.
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3.3 Discussion
Multiple glycine-activated iGluR subunits have recently been discovered by genome
sequencing of ctenophore species [24], including the comb jelly M. leidyi [14, 25]. A
special feature of these subunits is an interdomain salt bridge that has not been found
in iGluR subunits encoded in the genomes of a wide range of other organisms, in-
cluding mammals. Using a combination of crystallographic, biochemical, functional,
and computational approaches, we probed the effects of mutations in the salt bridge
to try to understand its role in ctenophore iGluRs. The mutants R703K and E423S,
which progressively weaken the interaction between residues 423 and 703, which form
the salt bridge in the WT protein, result in increased rates of recovery from desen-
sitization. This observation is consistent with our biochemical measurements that
demonstrate that the mutations decrease LBD affinity for glycine, thus establishing
that the lifetime of the desensitized state is determined in part by stability of the
agonist receptor complex. Crystal structures of the mutant LBDs show that rear-
rangements in the binding cleft are mostly limited to residues 703 and 423 and a
surrounding network of water molecules. Computational studies of the interdomain
salt bridge indicate that, in the WT LBD, the Arg703-Glu423 bridge is stable over a
wider range of LBD conformations than the Lys703-Glu423 counterpart present in the
R703K mutant. The crystallographic waters W9 and W7, which form part of a hydro-
gen bonding network in the binding pockets of the R703K and E423S glycine-complex
LBDs, respectively, are also found to be stably coordinated in the simulations.
Prior studies on GluA2, GluK2, and the NMDA receptor GluN1 and GluN2 sub-
units revealed only modest tuning of ligand apparent affinity by direct lobe 1-lobe
2 interactions [15, 16, 26–29]. The 1,000-fold stabilization of glycine binding by the
ML032222a salt bridge demonstrates that much stronger modulation is possible for
the LBD clamshell assembly. Functionally, a very high affinity for glycine has severe
consequences: ML032222a desensitizes rapidly and takes many minutes to recover
before it can respond to glycine again. On the other hand, the glycine-binding sub-
units of vertebrate NMDA receptors do not function as conventional ligand-gated ion
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channel subunits, which sense the pulsatile release of neurotransmitter at synapses,
but instead are likely to be continually bound by glycine or D-serine [30, 31]. Our
functional and biochemical analyses of perturbations to the salt bridge show how in-
terdomain contacts can tune receptor kinetics and thermodynamics over a very broad
range.
Based on the electrophysiological and biochemical data reported in this paper, as
well as prior studies of ML032222a and an iGluR LBD from another ctenophore, the
sea gooseberry P. bachei [14], we had expected the salt bridge to simply stabilize a
closed conformation for an open/closed transition. It was unclear, however, whether
this would be enough to confer the extraordinarily high stability observed for the
glycine complex. The results of our simulations reveal a surprisingly more complex
situation than we had previously envisioned. The conformational free energy analysis
reveals that the energy required to open the apo LBD sufficiently to allow glycine
binding is similar among the WT and mutant proteins. Opening the glycine-bound
LBD enough to allow glycine to exit, however, is energetically more expensive for the
WT protein than for the mutants. Because the salt bridge, in particular Arg703, is
positioned at what appears to be the likely point of entry into the binding pocket,
it serves as a barrier to incoming ligands. The salt bridge also blocks ligand egress
from the pocket if the binding pathways are assumed to be reversible. The effects
of the interdomain salt bridge may therefore be twofold: it restricts conformational
flexibility of the glycine-bound LBD while impeding the passage of glycine in and
out of the pocket. It is also possible that the strength of the salt bridge might be
tuned by the rotameric state of Glu423. The rotameric state appears roughly bimodal
with respect to whether the LBD is apo or glycine bound. Combined with the effects
mentioned above, a stronger salt bridge for the liganded complex would contribute to
the LBD’s high affinity for glycine. At a cleft opening of (𝜉1, 𝜉2) = (13, 16 Å), which is
sufficient to allow entry of a glycine ligand, the side chains of Arg703 and Glu423 are
separated by ∼8 Å. Is it possible that the glycine might transiently interact with the
guanidine of Arg703 and/or the carboxylate of Glu423 during ligand entry or exit?
Thus far, we have been unsuccessful in simulating glycine binding and unbinding,
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using approaches free of biasing potentials, to directly address this question, but we
speculate that the LBDs for other iGluR subtypes may be similarly complex in terms
of strategically positioned barriers.
The emerging structural biology of iGluR LBD conformational ensembles re-
veals that, although agonist binding results in the free energy landscapes adopt-
ing a single-minimum topology, apo LBDs can exhibit either single minima (as seen
for ML032222a, GluA2, and GluN2A) or multiple minima (as seen for GluN1 and
GluN3A) [17–19]. Glutamine-binding protein (GlnBP) is an example of a periplas-
mic binding protein (PBP) that exhibits a single stable conformational state for the
apo protein [32], whereas maltose-binding protein (MBP) is an example of a PBP
that exhibits metastable states for both open and closed conformations for the apo
protein [33, 34]. It should be noted that the iGluR LBD observations are based on
studies of isolated LBDs. In future work, we plan to calculate LBD PMFs in the con-
text of intact receptor tetramers containing the amino-terminal and transmembrane
domains. Although computationally expensive to perform, we anticipate that results
of these experiments will likely add to the complexity reported here.
3.4 Materials and Methods
3.4.1 Expression in Xenopus Oocytes and Functional Analy-
sis.
Full-length cDNAs for ML032222a, with R703K and E423S mutations created by
overlap PCR, were sequenced and cloned into pGEMHE [35], linearized with PmeI,
and used for cRNA expression using T7 polymerase (Ambion mMessage mMachine
transcription kit). Defolliculated stage 5-6 Xenopus oocytes obtained from Ecocyte
Bioscience were injected with between 0.1 and 1 ng cRNA and incubated at 18 ∘C in
ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, 2.5 mM
sodium pyruvate, gentamycin at 50 𝜇g/mL, pH 7.6). Two electrode voltage-clamp
recordings at a holding potential of -60 mV, with 3 M KCl agarose tipped electrodes
of resistance 0.1-0.8 MΩ, were performed 3-5 d after injection of cRNAs. The bath
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solution contained 100 mM NaCl, 1 mM KCl, and 5 mM Hepes, pH 7.5, to which
CaCl2 and MgCl2 were added as required. Amino acids were dissolved in recording
solution and applied by computer-operated solenoid valves essentially as reported
previously [36].
3.4.2 Protein Expression and X-Ray Crystallography.
Synthetic genes with codon optimization for expression in Escherichia coli for the
ML032222a LBD S1S2 construct with point mutations were created by overlap PCR,
expressed as soluble proteins, purified to homogeneity using metal affinity and ion
exchange chromatography, and crystallized as described previously [12, 14]. X-ray
diffraction data collected at Southeast Regional Collaborative Access Team (SER-
CAT) Advanced Photon Source (APS) was used to solve structures for the glycine
bound complexes of the R703K and E423S mutant LBDs by Fourier synthesis, using
the WT structure with mutant side chains truncated to CB atoms, and with alternate
conformations, ligand atoms, and solvent removed from the starting model. Iterative
cycles of model building and crystallographic refinement were carried out using COOT
[37] and PHENIX [38] until the 𝑅free value converged and Fo-Fc maps contained no
interpretable features.
3.4.3 Proteolysis Protection and Binding Assays.
Purified ML032222a S1S2 and the ML032222a R703K S1S2 mutant were denatured
in 4 M guanidinium, dialyzed to remove endogenous glycine, and then refolded using
buffers made with HPLC grade water; apo protein for the E423S mutant was success-
fully prepared by dialysis without unfolding. Digestions were performed with trypsin
at a ratio of 1:20 (wt/wt) at room temperature and then run on polyacrylamide gels.
ITC experiments with a VP-ITC calorimeter (MicroCal) were performed at 20 ∘C as
described previously [14].
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3.4.4 Free Energy Landscapes.
The protein conformational free energy landscapes 𝑊 (𝜉1, 𝜉2), or PMFs, were com-
puted using an umbrella sampling simulation strategy. A 2D order parameter, (𝜉1, 𝜉2),
is used to describe large-scale conformational transitions in the LBD. 𝜉1 and 𝜉2 each
specify the distance between the center of mass (COM) of an atom selection in lobe
1 and the COM of an atom selection in lobe 2. 𝜉1 is the distance between the atoms
N, CA, CB, C, and O of residues 498-500 (residues 92-94 of PDB ID codes 4YKI,
5CMB, and 5CMC) in lobe 1 and residues 704-705 (residues 145-146 of PDB ID codes
4YKI, 5CMB, and 5CMC) in lobe 2; 𝜉2 is the distance between the same atoms of
residues 423-425 (residues 17-19 of PDB ID codes 4YKI, 5CMB, and 5CMC) in lobe
1 and residues 730-731 (residues 171-172 of PDB ID codes 4YKI, 5CMB, and 5CMC)
in lobe 2.
The umbrella sampling windows consist of LBD conformations positioned in 1-
Å increments along 𝜉1 and 𝜉2. These coordinates were obtained via targeted MD
simulations using CHARMM [39] initiated from the following crystal structures: 4YKI
(glycine-bound WT LBD), 5CMB (glycine-bound R703K LBD), and 5CMC (glycine-
bound E423S LBD). Chain B was used; residue isomer A was used from the entries
where multiple options exist. Missing residues were built using the MODLOOP server
[40]. During the targeted MD simulations, RMSD restraints were applied separately
to each lobe to minimize intralobe structural distortions, and the glycine ligand was
restrained to remain docked to Arg131 in lobe 1.
One hundred ten umbrella sampling windows were used to compute each of the
PMFs. All simulations were performed using CHARMM and NAMD [41] with ex-
plicit solvent at 300 K. The all-atom potential-energy function PARAM27 for pro-
teins [42, 43] and the TIP3P potential energy function for water [44] were used. The
total simulation time for each of the apo WT, glycine-bound WT, apo R703K, glycine-
bound R703K, and apo E423S PMFs is ∼400 ns. The total simulation time for the
glycine-bound E423S PMF is ∼260 ns. A time step of 2 fs was used in the simulations.
The number of atoms in each simulation system is ∼31,000. Crystallographic waters
in each ligand-binding cleft were included in our models. Na+ and Cl− ions were
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added in the bulk solution to give 150 mM NaCl and an electrically neutral system.
Periodic boundary conditions were used with an orthorhombic cell with approximate
dimensions 88 × 64 × 56 Å. Harmonic biasing potentials with a force constant of 2
kcal/mol/Å2 centered on (𝜉1, 𝜉2) were used. Each PMF, 𝑊 (𝜉1, 𝜉2), was computed
using the weighted histogram analysis method (WHAM) [45, 46] to unbias and re-
combine the sampled distribution functions in (𝜉1, 𝜉2) from all windows. A timestep
of 20 fs was used in the WHAM calculations. To safeguard against ligand dissocia-
tion in open LBD conformations, an asymmetric harmonic potential (force constant
of 10 kcal/mol/Å2) was applied to the distance between the 𝛼-carboxylate oxygen
atoms of the ligand and the guanidinium nitrogen atoms of Arg131. The asymmet-
ric potential resulted in the restraint being active only when the distance exceeded
3.2 Å. This restraint is not expected to adversely affect conformational sampling be-
cause dissociation events were never observed in test simulations involving open LBD
conformations.
3.4.5 Block Averaging.
The statistical uncertainty in each PMF was evaluated using the approach of block
averaging [47]. For each PMF, the time series in (𝜉1, 𝜉2) was divided into 10 blocks,
WHAM was used to calculate a PMF from the data in each block, and then the SD in
the 10 PMFs was calculated. Using 5-15 blocks all gave qualitatively similar results.
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Fig. 3-1: Salt bridge mutants speed recovery from desensitization (A) Crys-
tal structure of the WT ML032222a iGluR LBD (PDB ID code 4YKI). Lobe 1 is
colored gold and lobe 2 colored pale green; labels indicate secondary structure helix
assignments. (B) Zoomed view of the entrance to the WT ML032222a binding site
showing the interdomain salt bridge formed by the side chains of Glu423 in lobe 1
(gold) and Arg703 in lobe 2 (pale green). (C) WT ML032222a responses to paired 5-s
applications of glycine in which the interval between the first and second application
was varied from 10 s to 5 min to measure the rate of recovery from desensitization.
(D) ML032222a R703K mutant responses to paired 5-s applications of glycine in
which the interval between the first and second pulse was varied from 10 to 90 s. (E)
ML032222a E423S mutant responses to paired 5-s applications of glycine in which
the interval between the first and second pulse was varied from 2 to 5 s. (F) Bar plot
showing the rate constant for recovery from desensitization for WT ML032222a and




Fig. 3-2: Salt bridge mutants lower affinity for glycine. (A) Proteolysis
protection assays for refolded WT ML032222a S1S2 (Top); refolded R703K mutant
(Middle); and exhaustively dialyzed E423S mutant (Bottom). (Left) Coomassie blue
stained SDS/PAGE experiments show the time course of digestion by trypsin; (Right)
protection by 1 mM glycine; lanes show a 31-kDa marker (MW), uncut protein (UC),
and samples at the indicated times in minutes after addition of trypsin. (B) Titra-
tion of refolded ML032222a R703K by glycine analyzed by ITC, with raw (Top) and
integrated (Bottom) data fit with a binding isotherm of 𝐾𝑑 = 28 nM. (C) Titration
of ML032222a E423S by glycine analyzed by ITC, with raw (Top) and integrated
(Bottom) data fit with a binding isotherm of 𝐾𝑑 = 2.5 𝜇M.
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Fig. 3-3: Salt bridge mutant crystal structures. (A) Crystal structure stere-
oview of the WT ML032222a binding pocket, with a 1.21-Å resolution 2𝑚Fo-DFc elec-
tron density map contoured at 2𝜎 for ligand and protein, and 3𝜎 for water molecules;
secondary structure elements for the S1 and S2 segments are colored gold and green,
respectively; side chains involved in ligand binding and interdomain contacts are
drawn in stick representation, with ion pair and hydrogen bond contacts drawn as
dashed lines; water molecules flanking the entrance to the binding site are shown
as red spheres; note the hydrogen bond contact of W9 with the Glu423 side chain;
the surface of the ligand binding pocket is shaded in gray. (B) Crystal structure
stereoview of the ML032222a R703K mutant binding pocket colored as above with a
1.34-Å resolution 2𝑚Fo-DFc electron density map contoured at 2𝜎; note the change
in side chain torsion angle for Glu423, movement of water molecules W7 and W8,
and interposition of W9 between the side chains of Glu747 and Asp497. (C) Crys-
tal structure stereoview of the ML032222a E423S mutant binding pocket colored as
above with a 1.28-Å resolution 2𝑚Fo-DFc electron density map contoured at 2𝜎 for
ligand and protein and 2.5𝜎 for water molecules; note movement of W7 into the posi-





Fig. 3-4: Comparison of LBD cavity sizes and water molecule networks in
the WT, R703K, and E423S mutants. (A) Stereoview of a superposition of the
LBD cavity for WT (gray) and R703K (pale green). (B) Stereoview of a superposition
of the LBD cavity for WT (gray) and E423S (pale orange). (C) Stereoview of su-
perpositions using domain 1 main chain coordinates for residues forming the glycine
binding site, with carbon atoms and water molecules colored pale green for R703K
and pale orange for E423S, respectively; for WT, carbon atoms are gray with water
molecules colored red.
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Fig. 3-5: Conformational free energy landscapes.(A) The order parameter
(𝜉1, 𝜉2) used to describe large-scale conformational transitions in the ML032222a LBD.
𝜉1 and 𝜉2 each represent the distance (dashed line) between the upper and lower lobes
of the protein at the centers of mass of the highlighted atoms. Disulfide bonds are
shown in red. (B) Free energy landscapes for the WT apo state (Top) and glycine
complex (Bottom) plotted as 2D PMFs (Left) and 1D PMFs (Right). Contour lines
correspond to a difference of 1 kcal/mol, with cooler colors being lower in free energy
(see the color bar). Fig. 3-7 shows the SDs for the 2D PMFs, as determined by
block averaging. For the 1D PMFs, the red-shaded region indicates the SD of the
free energy. The locations of crystal structures are indicated by yellow dots. (C) Free





Fig. 3-6: Comparison of free energy basins for the apo and glycine complex
LBDs. (A) The lowest three contour lines from the 2D PMFs in Fig. 3-5 are shown
for the WT LBD. Apo is shown in black, and the glycine complex is shown in red.




Fig. 3-7: The SD of the 2D PMFs . (A) SD in Fig. 3-5B. (Left) The apo
state. (Right) The glycine complex. SDs are shown in kcal/mol (see the color bar),
as determined by block averaging. The contour lines are taken from the 2D PMFs
(Fig. 3-5). (B) SD in Fig. 3-5C. (C) SD in Fig. 3-5D.
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Fig. 3-8: Salt bridge conformational dynamics. (A) Interactions between
Arg703 and Glu423 for the WT LBD as a function of cleft closure. (Left) The
apo state. (Right) The glycine complex. Average distances are shown in Ångstroms
(see the color bar); SDs are shown in Fig. 3-9 A and B. The contour lines are taken
from the 2D PMFs (Fig. 3-5). (B) Interactions between Lys703 and Glu423 for the
R703K mutant LBD. (C) Distance between the Glu423 C𝛿 atom and the Asp497 C𝛾
atom for the WT LBD as a function of cleft closure. (Left) The apo state. (Right)
The glycine complex. Average distances are shown in Ångstroms; SDs are shown in
Fig. 3-9 C and D. The contour lines are taken from the 2D PMFs (Fig. 3-5). (D)




Fig. 3-9: The SD of distance measurements involving the salt bridge
residues (Fig. 3-8). (A) SD in Fig. 3-8A. (Left) The apo state. (Right) The
glycine complex. SDs are shown in Ångstroms (see the color bars). The contour lines
are taken from the 2D PMFs (Fig. 3-5). (B) SD in Fig. 3-8B. (C) SD in Fig. 3-8C.
(D) SD in Fig. 3-8D.
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Fig. 3-10: Occupancy of binding pocket water molecules as a function of
cleft closure. (A) For the R703K mutant LBD, the binding pocket water corresponds
to W9 in Fig. 3-3B and is coordinated by Glu423, Asp497, and Glu747. (Left) The
apo state. (Right) The glycine complex. Cooler colors indicate lower occupancy. The
contour lines are taken from the 2D PMFs (Fig. 3-5). (B) For the E423S mutant LBD,
the water corresponds to W7 in Fig. 3-3C and is coordinated by Ser423, Asp497,
and Arg703.
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Fig. 3-11: Glycine accessibility as a function of cleft closure. (A) Tunnels
that allow a glycine ligand to access its binding pocket from bulk solvent, found
using CAVER Analyst, are shown in green. The primary access tunnel to the pocket
is in the center; the lateral tunnels are crevices that feed into the central tunnel.
Bottleneck residues for the central tunnel are Phe469 and Arg703, shown in red.
Glu423 also lines the central tunnel and is shown in magenta. A minimum distance
of ∼10 Åbetween the side chains of residues 469 and 703, measured at C𝛾 atoms, is
required for glycine passage. Disulfide bonds are shown in orange. The example LBD
conformation shown corresponds to (𝜉1, 𝜉2) ∼ (13, 16 Å). In this conformation, the
Arg703-Glu423 salt bridge is broken. (B) Distance between the side chains of Phe469
and Arg703, measured as described in A, for the WT BD. (Left) The apo state.
(Right) The glycine complex. Average distances are shown in units of Ångstroms (see
the color bar); SDs are shown in Fig. 3-12. The dashed box indicates the region of
integration for open LBD conformations. The contour lines are taken from the 2D
PMFs (Fig. 3-5). (C) Distance between the side chains of Phe469 and Lys703 for the
R703K mutant LBD. (D) Distance between the side chains of Phe469 and Arg703 for




Fig. 3-12: The SD of distance measurements between Phe469 and
Arg/Lys703 (Fig. 3-11). (A) SD in Fig. 3-11B. (Left) The apo state. (Right)
The glycine complex. SDs are shown in Ångstroms (see the color bar). The contour
lines are taken from the 2D PMFs (Fig. 3-5). (B) SD in Fig. 3-11C. (C) SD in
Fig. 3-11D.
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Table 3.1: Data collection and refinement statistics
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Table 3.2: Free energy of conformational change in the LBD
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Ionotropic glutamate receptors (iGluRs) are found throughout the brain and are
essential for excitatory synaptic transmission. The receptor is activated when the neu-
rotransmitter glutamate binds to bilobed ligand-binding domains (LBDs), but very
little is known about how glutamate reaches its recessed binding pocket and how
ligand binding is coupled to protein conformational changes. Here we report the pro-
cess of glutamate binding to a prototypical glutamate receptor, GluA2, in atomistic
detail using unbiased molecular simulations. Charged residues on the surface of the
LBD form binding pathways that facilitate glutamate binding by effectively reduc-
ing a three- dimensional diffusion process to a spatially-constrained two-dimensional
one. Free energy calculations identify surface residues that metastably bind gluta-
mate and help funnel it into the binding pocket. Surprisingly, these simulations also
reveal that glutamate can bind in an inverted conformation and also reorient while
in the binding pocket. Electrophysiological recordings demonstrate that eliminating
these transient binding sites reveals a selective and unique kinetic signature of slowed
activation and deactivation, consistent with slower glutamate binding and unbinding.
These results suggest that binding pathways have evolved to optimize rapid responses
of AMPA-type glutamate receptors at central nervous system synapses.
4.1 Background
The "clock speed" of the brain is set at ∼1 kHz by the width of action potentials,
the release rate of synaptic vesicles, and the duration of synaptic potentials [1, 2].
Fast activation and deactivation of synaptic neurotransmitter receptors is therefore
essential for normal signalling in the nervous system. One of the fastest-operating
receptors is the AMPA-type ionotropic glutamate receptor (iGluR) [3], a ligand-gated
ion channel found throughout the brain [4]. Activation of these receptors is the
final step in a cascade that allows cells releasing glutamate to excite downstream
target neurons with millisecond precision [5]. Each receptor has four binding sites for
glutamate that resemble clamshells, termed ligand-binding domains (LBDs). The four
LBDs in each receptor assemble as a dimer of active dimers [6]. Because glutamate-
bound LBDs are closed, ligand binding is thought to pull open the gate of the attached
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ion channel pore. Alternatively, binding can drive separate conformational changes
that result in an unresponsive, desensitized receptor. A paradox of AMPA receptor
activation is how the dynamics of both binding and unbinding of glutamate are fast
enough in order to allow both the onset and termination of activity to be rapid, yet
activation is robust and selective.
Over 100 high-resolution structures of genetically isolated iGluR LBDs have been
determined, in complex with agonists and competitive antagonists, as well as in
the apo state. These structures reveal common modes of ligand binding within the
cleft [6]. Computational analyses have shed light on both LBD and ligand dynam-
ics and energetics [7–18]. Neither the structural nor computational studies, have
comprehensively shown how glutamate finds its way into the binding site or how
large-scale conformational changes in the LBD are coupled to glutamate binding. For
example, does glutamate diffuse directly from bulk solvent into its binding pocket,
only contacting the protein randomly, or does glutamate follow distinct pathways on
the surface of the LBD to find its way into its pocket? If the latter, what struc-
tural features make up the pathways, and what is the nature of the protein-ligand
interactions therein? In this study, long-timescale molecular dynamics simulations
(totaling nearly 50 𝜇s) and free energy calculations of the GluA2 receptor suggest
that strategically-positioned flexible sidechains on the surface of the LBD metastably
interact with glutamate to help funnel it into its recessed binding pocket, where it
adopts two possible poses. These results were used to guide the design of a panel
of LBD mutants that were tested using electrophysiological recordings. Elimination
of the transient binding sites was found to slow both activation and deactivation
of the receptor. Taken together, these results suggest that glutamate, and perhaps
other iGluR ligands as well, binds via distinct pathways on the surface of the LBD,
and disruption of these pathways significantly impacts the functional kinetics of the
receptor.
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4.2 Results and Discussion
4.2.1 Glutamate binds via preferred pathways and metastable
interactions
In order to examine the processes by which a glutamate ligand either associates with
or dissociates from the GluA2 AMPA receptor LBD, we performed unbiased all-atom
MD simulations with explicit solvent using special-purpose hardware [19] to generate
21 trajectories with an aggregate of 49.1 /𝑚𝑢s. The four LBDs of an iGluR are
arranged as a dimer of dimers; we simulated glutamate binding in both LBD dimers
and monomers. The binding of glutamate is thought to involve: ligand entry into an
open, solvent-exposed binding cleft, ligand docking to R485 in Lobe 1 of the LBD,
then large- scale conformational changes that close the cleft, securing the ligand [20].
After glutamate has docked, cleft closure proceeds when the ligand, attached to R485,
also attaches to E705 in Lobe 2 [21].The ligand forms both of these Lobe 1 and Lobe
2 interactions in all of the simulated binding trajectories.
In our simulation systems (see Table 4.1 Table 4.2), glutamate ligand molecules
were initially placed at random positions and orientations in bulk solvent, similar to
the approach of Dror et al. [22], at least 8 Å away from any non-water molecules.
The effective ligand concentrations ranged from 3.9 mM (single ligand in a monomer
system) to 71 mM (20 ligands in a dimer system). These concentrations are somewhat
higher than estimates of the peak glutamate concentration during synaptic transmis-
sion (1-10 mM) [23, 24], but our goal was to maximize the likelihood of observing
multiple independent binding events within our allocated simulation timeframe. De-
spite the high concentrations, we did not observe any artifactual ligand- ligand or
protein-ligand interactions. In all but one of the binding trajectories (see 4.7), the
two negatively charged carboxyl groups of glutamate are exploited by positively-
charged side chains at the periphery of the binding cleft. Strikingly, glutamate was
passed from one residue to the next by a select set of residues that "funnel" the
neurotransmitter, via a series of metastable interactions, into its binding site.
In one such trajectory (Fig. 4-1, Movie S1), the ligand first contacts the LBD at
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R453. From there, its 𝛾-carboxyl group swings toward Lobe 2 to interact with helix
F residues E657, R660, and R661. Mutations in this region, a prominent metastable
interaction site (occurring in three out of six binding simulations), alter AMPA re-
ceptor function [25]. R660 is conserved between AMPA and NMDA receptors; in
kainate receptors, R660 and R661 are replaced by lysine residues (Fig. 4-8a). The
guanidinium group of R485 rotates dramatically out of the binding pocket to contact
the ligand. This surprising conformational flexibility occurs via rotations of −106∘,
−127∘, −136∘, and −111∘ around the R485 sidechain’s 𝜒1, 𝜒1, 𝜒3, and 𝜒4 torsion an-
gles, respectively (Fig. 4-1, e-i). The ligand remains tethered to R485 as it leaves the
metastable site, being pulled into the binding cleft. Finally, the cleft closes to secure
the bound ligand in the crystallographic pose. Details of individual trajectories are
provided in 4.7.
The binding pathways in the dimer and monomer simulations are very similar.
Given the functional independence of binding processes and the location of the path-
ways at the periphery of the LBD tetramer (Fig. 4-8b), we expect that the pathways
we observe are the same in full-length, tetrameric forms.
In all trajectories, K730, in the hinge region between Lobes 1 and 2, shows substan-
tial conformational flexibility and alternates between forming salt bridge interactions
with E705 in Lobe 2 and D728 in the hinge. From our simulations, it is unclear how
much these interactions contribute to "locking" the LBD closed, as first proposed by
Armstrong and Gouaux [21]. Water molecules were observed to occupy approximately
the same positions in the cleft as seen in crystal structures [21].
4.2.2 Potential of mean force for binding and unbinding
To understand the energetics of funneling in each of the pathways, we computed a
three- dimensional free energy landscape, or potential of mean force (PMF), from our
binding and unbinding trajectories. The PMF, shown in Fig. 4-2a, indicates three
possible ligand binding pathways. Contouring the PMF at lower energies revealed
sites of metastable protein-ligand interactions (Fig. 4-2b-d). Situated inside the
binding pocket, site 0 is the global free energy minimum, set to 0 kcal/mol. The
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next most stable sites, sites 1, 2, and 3, are local minima with free energies of 0.29,
0.83, and 0.75 kcal/mol, respectively, located at positions where the ligand forms
metastable interactions with the LBD. Sites in bulk solvent, on the other hand, have
free energies of about 3.12 kcal/mol. The ligand traverses pathway 1 in about half of
the trajectories, pausing at site 1 prior to binding at site 0. In pathway 2, the ligand
interacts with sites 2 and 1 prior to binding. In pathway 3, the ligand transitions
from site 3 directly to site 0. Residue-ligand interactions play a role in passing the
ligand from each site to the next. In particular, helix F residues (E657, R660, and
R661) are involved in interactions at site 1 and 2 as well as transitions from site 2
to site 1 and from site 1 to site 0. K449 is involved in shuttling the ligand into the
binding pocket from site 3. A list of the residues that interact with the ligand at each
site is provided in the legend for Fig. 4-2a. An error analysis of the PMF is provided
in Fig. 4-9.
The association rate constant calculated from our binding trajectories, 𝑘on =
1.4 × 107 M−1s−1 , using the approach of Dror et al. [22], agrees closely with the
experimentally measured value of 1.6 × 107 M−1s−1 for the GluA4 LBD [26] (Ta-
ble 4.2). To our knowledge, no experimentally measured 𝑘on for the GluA2 LBD has
been reported, but the submillisecond activation lag at 10 mM glutamate reported
here and elsewhere is consistent with this value.
4.2.3 Glutamate can bind in an inverted pose
Two of the binding trajectories resulted in glutamate binding into the crystallograph-
ically observed pose [21], in which the ligand’s 𝛼-carboxyl group is anchored by R485
in Lobe 1 while the 𝛾-carboxyl group is stabilized by the backbone amides of S654 in
Lobe 2 (Fig. 4-3a). In the crystal structure, the 𝛾- carboxyl group also interacts with
the backbone amide of T655 in Lobe 2, but this interaction was not observed in our
binding trajectories; further closure of the LBD would be required for this interac-
tion. The other four trajectories unexpectedly resulted in glutamate binding into an
"inverted" pose, in which the 𝛾-carboxyl group binds to Lobe 1, and the 𝛼-carboxyl
group binds to Lobe 2 (Fig. 4-3b and Fig. 4-10, Movie S2). The lack of preference for
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binding the 𝛼- or 𝛾-carboxylates of glutamate at metastable sites presents a paradox.
How is glutamate delivered efficiently into the pose seen in crystallographic exper-
iments? Indeed, in several of the simulations, glutamate adopts an inverted pose.
However, in one simulation (Fig. 4-11, Movie S3, Tdim2 in Table 4.1), glutamate
rotates from the crystallographic pose to the inverted pose, suggesting interconversion
between poses is possible. In this case, the binding cleft was not fully closed. Free en-
ergy landscapes governing cleft closure have been described using the two-dimensional
order parameter (𝜉1, 𝜉2) (Fig. 4-3c)( [10, 14, 17, 27]). The extent of cleft closure for
LBD conformations with glutamate bound in the inverted pose is not as great as that
seen in crystal structures or in Tdim1 (Fig. 4-3d, Movie S1). It is possible that an
extension of Tdim2 could have resulted in the ligand returning to the crystallographic
pose. In support of this notion, MD simulations of drug binding to G-protein-coupled
receptors showed that a drug initially bound in a non-crystallographic pose eventually
converted to the crystallographic pose [22]. Our measurements do not indicate how
stable the non-crystallographic, inverted pose is, but this binding mode could cause
glutamate to act as a partial agonist with a smaller degree of cleft closure. Individual
AMPA receptor activations show substantial sublevel activity, connected to LBD oc-
cupancy [28]. Stochastic fluctuations in the single channel current could additionally
reflect dynamic conversions between crystallographic and non-crystallographic ligand
poses.
4.2.4 Unbinding pathways mirror binding pathways
We also simulated ligand dissociation trajectories, which we initiated from either
crystal structure-like configurations in which the LBD is fully closed with glutamate
in the crystallographic pose (PDB: 1FTJ) or ligand-docked configurations in which the
LBD is semi- closed or open (Table 4.1). The latter trajectories were continuations
of prior ligand-association trajectories. In general, for both the LBD dimer and
monomer systems, binding and unbinding pathways appear to be the reverse of each
other, with free energy barriers being traversed in opposite order. The ligand exited
from the 𝜉1 side of the binding cleft in all five dissociation events involving the dimer.
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For the monomer, the ligand exited from the 𝜉1 side in four dissociation events and
from the 𝜉2 side in two events.
4.2.5 Disrupting binding pathways selectively slows both ac-
tivation and deactivation
The simulations suggest that clusters of charged residues along the binding pathways
should interact with glutamate during both association and dissociation. To test this
hypothesis, we designed a set of single, double and triple mutants, removing or revers-
ing the polarity of charged sidechains at each metastable site in turn (Fig. 4-4a). We
hypothesized that these mutations should alter receptor activation, deactivation, and
perhaps recovery from desensitization. Given that the metastable sites are formed
by flexible residues lacking interactions with other parts of the receptor, we expected
little effect of the mutations on downstream gating conformational changes. Addi-
tionally, we expected that entry into desensitization, which likely involves neither
binding nor conformational changes of the individual LBDs, should be unaffected
Association is the first step in the sequence of events from resting to activated
states. Therefore, we applied long (200 ms) pulses of 10 mM glutamate, to measure
the activation as a proxy for glutamate association, with only minimal contamination
from the ∼50-fold slower desensitization process. Activation of wild-type (WT) GluA2
by 10 mM glutamate is very fast, with a 10-90% rise time of 200 ± 30 𝜇s. The rise
time is probably slowed by the rate of solution exchange onto the excised patch.
Strikingly, a substantial 3-fold increase in the 10-90% rise time during activation,
𝑡rise, was observed for R453D and RDK-AAA (𝑡rise = 645 ± 60 and 760 ± 70 𝜇s,
respectively; P < 0.005 vs. WT GluA2, 𝑡-test, 𝑛 = 3-7; Fig. 4-4b,c; Table 4.3).
We next investigated receptor deactivation, a process limited by the glutamate
unbinding rate, by applying short (1 ms) pulses of 10 mM glutamate. WT GluA2
deactivates rapidly, with a deactivation time constant, 𝜏deact, of 1.5 ± 0.2 ms. Mu-
tating residues involved in metastable site 1, we observed a robust increase in 𝜏deact
for R453D (𝜏deact = 3.6 ± 0.1 ms; Table 4.3) and the triple alanine mutant, R453A-
D456A-K458A (denoted RDK-AAA; 𝜏deact = 3.7 ± 0.1 ms), compared with WT
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GluA2 (P = 0.003, 𝑡-test, 𝑛 = 3-5) (Fig. 4-4d).
Single substitutions on helix F (R660 and R661; sites 1 and 2) had little effect
on activation or deactivation, but the triple mutant E657A-R660A-R661A (denoted
ERR-AAA, Fig. 4-5a) exhibited the same profile of slower activation (𝑡rise = 550 ±
80 𝜇s; Fig. 4-5b; Table 4.3) and deactivation (𝜏deact = 3.8 ± 0.4 ms; Fig. 4-5c) as
the RDK-AAA mutant. A comparison of 𝐸𝐶50 values for WT GluA2 (𝐸𝐶50 = 330 ±
50 𝜇M) and ERR-AAA (𝐸𝐶50 = 410 ± 30 𝜇M), revealed that the apparent affinity of
the ERR-AAA mutant for glutamate is similar to that of WT (P = 0.5; 𝑡-test, 𝑛 = 3)
(Fig. 4-12d). This result is expected if mutations remove metastable interactions but
do not affect the initial or final conformational states, revealing a distinct mechanism
to previous reports of LBD mutations that change binding [25,29].
We also tested the RDK-AAA mutant with 50 mM glutamate, to ensure that
ligand diffusion was not a factor in slowed activation. Both activation and deactivation
remained substantially slower than in WT GluA2 (𝑡rise = 660 ± 70 𝜇s; P = 0.01 vs.
WT GluA2, 𝑡-test, 𝑛 = 3; 𝜏deact = 3.7 ± 0.1 ms; P = 0.0003 vs. WT GluA2, 𝑡-test
, 𝑛 = 3; Fig. 4-12, a, b, Table 4.3). This result strongly suggests that the binding
kinetics are principally altered by mutations at these metastable sites.
In order to determine how the ERR-AAA mutant perturbs glutamate binding, we
performed unbiased simulations involving this mutant LBD (Movie S4, Table 4.4).
PMF calculations indicate that this LBD lacks metastable interactions along Path-
ways 1 and 2, proximal to helix F (Fig. 4-5e). The dominant binding pathway, which
does not involve helix F interactions, is similar to Pathway 3 in the WT LBD.
As expected for mutations that perturb only binding kinetics, desensitization was
weakly perturbed by mutations to the ligand binding pathways. The time constant of
entry to desensitization, 𝜏desen, for RDK-AAA, ERR-AAA, and single point mutants,
were similar to WT GluA2 (Fig. 4-13a,b, and Fig. 4-12c, and Table 4.3). For
most mutants, the time constant of recovery from desensitization was similar to WT
GluA2 (60 ± 5 ms), but the R453D and RDK-AAA mutants recovered about twice
as fast (P=0.01 and P=0.02, 𝑡-test, 𝑛 = 3; Fig. 4-13c,d). These results support the
idea that entry to and recovery from desensitization occur with the clamshell closed
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and glutamate stably bound, even though glutamate must eventually unbind during
recovery.
The second set of mutants that we generated targeted pathway 3. The D447A-
K449A double mutant in Lobe 1 (DK-AA) slowed activation (𝑡rise = 410 ± 40 𝜇s ; P
= 0.01, vs. WT GluA2, 𝑡-test, 𝑛 = 4-6, Fig. 4-6 a, b, Table 4.3) compared with WT
GluA2. The very poor expression of this mutant precluded a robust measurement of
deactivation (𝜏deact = 3 ± 0.3 ms; P = 0.1 vs. WT GluA2, 𝑡-test, 𝑛 = 3; Fig. 4-4C).
The R684A-E688A double mutant in Lobe 2 (RE-AA), which targeted site 3, slowed
both 𝑡rise and 𝜏deact to a greater extent (𝑡rise = 590 ± 50 𝜇s and 𝜏deact = 4.9 ± 0.7 ms;
P < 0.05, 𝑡-test, 𝑛 = 3, Fig. 4-6b,c). For the RE-AA mutant, we also observed an
apparent acceleration in of recovery from desensitization (𝜏rec = 13 ± 1 ms, 𝑛 = 3;
Fig. 4-14) compared with WT GluA2, although again, poor expression made proper
estimation of the recovery time constant difficult.
4.2.6 Off-pathway mutants do not perturb binding
Substantial charge swap mutations could have non-specific effects on binding such as
altering binding domain structure, electrostatic profiles or intersubunit interactions.
Therefore, as negative controls, we generated complementary, off-pathway mutations
that our simulations predicted did not interact with glutamate during binding and
unbinding. Two triple alanine mutations were generated: K409A-K410A-E422A (de-
noted KKE-AAA) in Lobe 1 and R715A- K716A-D769A (denoted RKD-AAA) in
Lobe 2. These off-pathway mutants had smaller effects on kinetics, (𝑡rise = 100 ±
5 𝜇s, 𝜏deact = 2.4 ± 0.1 ms for RKD; 𝑡rise = 310 ± 10 𝜇s, 𝜏deact = 1.1 ± 0.1 ms
for KKE; Fig. 4-6d-f). Their kinetics conformed to previously published mutants
that influence closed-cleft stability. Quite distinct from the metastable binding sites
presented here, for RKD-AAA slower deactivation was accompanied by faster acti-
vation (Table 4.3; indicative of an increase in affinity). For KKE-AAA, the results
were inverted, with faster deactivation and slower activation slower (consistent with
reduced glutamate affinity).
For most of the mutants tested, the decay rate is slowed more profoundly than
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the opening rate. The decay time constant varies linearly as a function of the activa-
tion time, and changes in the decay are roughly 8-fold larger than that of activation
(Fig. 4-7c). Simulated currents using previously published kinetic models of AMPA
receptor activation [29] show that this relationship is precisely what is expected from
slowing glutamate association and dissociation rates by equal amounts. Moreover,
these calculations were performed with realistic concentration jump profiles [30], in-
dicating the physically plausible solution exchange rate of about 300 𝜇s would be
expected to yield a very similar, roughly linear relationship between activation and
deactivation times (Fig. 4-7). Notably, the off-pathway mutants KKE-AAA and
RKD- AAA (Fig. 4-6d-f) lie away from the linear relation between activation and
decay time (Fig. 4-7c).
Taken together, these results strongly support the hypothesis that these metastable
sites predicted in silico form preferential pathways to guide glutamate in and out of
its binding site.
4.3 Conclusion
By combining long unbiased simulations with direct measurements of receptor kinet-
ics, we could show a key role for charged residues in facilitating fast neurotransmitter
access to a deep binding site. These studies show that neurotransmitter binding is
a directed process for which kinetics have been optimized (presumably by evolution)
without altering overall ligand affinity. Previous work has shown that electrodiffusion
of glutamate in the synaptic cleft speeds up neurotransmission [31]. Our experiments
reveal a strikingly elaborate management of ligand transport by AMPA receptors,
whereby flexible positive charges ensure that glutamate binding reactions are fast.
The existence of these pathways is surprising, and the fact that they alter the kinet-
ics of receptor activity indicates that the molecular mechanisms that determine the
action of neurotransmitters at receptors are more complex than previously thought.
Given that electrostatic interactions are also important for coordination in other neu-
rotransmitter binding sites [32], these principles of ligand funnelling may be general.
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4.4 Materials and Methods
4.4.1 Simulation system preparation.
The initial atomic models for both the monomer and dimer systems were constructed
from the crystal structure of the GluA2 ligand-binding core (S1S2) in complex with
glutamate (PDB ID: 1FTJ). Missing amino acid residues were built using the Mod-
loop server [33], and missing sidechains were built using SCWRL4 [34]. Crystallo-
graphic waters in the ligand-binding cleft were included. The monomer system, which
contained a total of 47,227 atoms, was solvated with 14,369 water molecules and neu-
tralized by adding Na+ and Cl− ions to the bulk solution until the salt concentration
was 150 mM NaCl. Periodic boundary conditions were imposed on an orthorhombic
cell with approximate dimensions 88 Å × 68 Å × 78 Å. The dimer system, which
contained a total of 56,217 atoms, was solvated with 15,951 water molecules and neu-
tralized to maintain 150 mM NaCl. Periodic boundary conditions were imposed on
an orthorhombic unit cell of approximate dimensions 96 Å × 78 Å × 78 Å. The sys-
tem was energy minimized and equilibrated using constant pressure and temperature
(NPT) conditions at 1 atm and 300 K with a timestep of 2 fs. The all-atom poten-
tial energy function PARAM27 for proteins [35, 36] and the TIP3P potential energy
function for water [37] were used. Electrostatic interactions were computed using the
particle mesh Ewald (PME) algorithm and short-range, non-bonded interactions were
truncated to 12 Å. The initial protein configuration of the system was relaxed with
Langevin dynamics in the presence of harmonic restraints at constant volume for 30
ps before the barostat was switched on at 1 atm for a further 60 ps of simulation in
NPT conditions. The cell dimensions were allowed to vary for 2 ns in NPT conditions
before reaching the final box size. A 4 ns pre-production run in constant volume and
temperature (NVT) conditions was carried out from which five, ligand-bound, start-
ing coordinates for the monomer, and one, ligand-bound, starting coordinates for the
dimer were selected for long-timescale simulation. The pre-production run was per-
formed using NAMD 2.9 [38], while minimization and equilibration procedures were
done in CHARMM [39].
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4.4.2 System preparation for the ERR-AAA simulations.
Starting coordinates were selected from trajectory Tmon2, which involved the monomer
system containing 10 ligands. Residues E657, R660, and R661 were mutated to
alanine in CHARMM by deleting the side chain atoms and replacing with methyl
groups. The salt concentration was adjusted to maintain 150 mM NaCl. The mutant
system containing 47,080 atoms was energy minimized and briefly equilibrated in a 2
ns pre-production run in constant NVT conditions.
4.4.3 Simulations with increased ligand concentration.
For the LBD monomer, 10 ligands were added at arbitrary positions in bulk solvent,
each greater than 20 Å from the binding pocket, to a previously prepared system
containing an LBD in an open conformation. Salt concentration was adjusted for
ligand charge to maintain 150 mM NaCl. A 2 ns pre-production run was carried out
in constant NVT conditions. For the LBD dimer, 20 ligands were added at arbitrary
positions in bulk solvent greater than 20 Å from the binding pocket to a previously
prepared system containing open conformations of the LBDs. Salt concentration was
adjusted for ligand charge to maintain 150 mM NaCl. A 2 ns pre-production run was
carried out in constant NVT conditions.
4.4.4 MD simulations.
All production runs used the NPT ensemble at 1 atm and 300K. Bond lengths for
hydrogen atoms were constrained using the M-SHAKE algorithm [40]. An r-RESPA
integrator [41] was used with a timestep of 2 fs; long-range electrostatics were com-
puted every 6 fs. Long-range electrostatics interactions were calculated using the
k-space Gaussian split Ewald method [42] with a 64 Å × 64 Å × 64 Å grid, 𝜎 = 2.02
Å, 𝜎𝑠 = 1.29 Å. Short-range interactions including van der Waals and short-range
electrostatics were truncated at 9 Å. To prevent overall rotational and translational
motion of the protein, positional harmonic restraints were applied on the backbone
atoms of residues 426-428 (residues 37-39 in 1FTJ), residues 474-476 (residues 85-87
in 1FTJ), and residues 490-492 (residues 101-103 in 1FTJ) with a force constant of 0.3
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kcal mol1 Å−2. All productions simulations were carried out on the special purpose
Anton machine at the Pittsburgh Supercomputing Center [19]. Production simula-
tions for the ERR-AAA mutant protein were carried out on the Anton2 machine at
the PSC [43]. Simulations on Anton2 were carried out as they were on Anton, except
using a temperature of 310K, which is the default for Anton2. A total of 21 trajec-
tories were generated for an aggregate simulation time of 49.1 𝜇s: 11.8 𝜇s involved
WT dimers, 36.1 𝜇s involved WT monomers, and 1.2 𝜇s involved the ERR-AAA
monomer.
4.4.5 Ligand binding PMF.
The trajectories containing the monomeric LBD with 10 ligands (Tmon2,3) was sampled
at 0.12 ns intervals. Cartesian coordinates for the ligand’s non-hydrogen atoms,
?⃗?, were measured and used as three-dimensional order parameters to describe the
states along the binding pathway. Each frame in the trajectory was aligned with
respect to the backbone atoms of the LBD. The density of atomic positions, 𝜌(?⃗?),
was computed using a hard sphere van der Waals approximation onto a discretized
grid with a spacing of 0.5Å × 0.5 Å × 0.5 Å and subsequently weighted to produce the
free energy maps using the standard Boltzmann re- weighting scheme, i.e., 𝑊 (?⃗?) =
−𝑘𝐵𝑇 log[𝜌(?⃗?)] . The statistical uncertainty in the PMF was determined using the
approach of block averaging [44] (Fig. 4-9). The trajectory was subdivided into 10
blocks, and a PMF was calculated for each block. The standard deviation in the 10
PMFs was calculated. Using 5âĂŞ15 blocks all gave qualitatively similar results.






, where 𝑁𝑏 is the total number of binding events; 𝑡𝑖 is the time the
ligand spends in bulk solvent, [𝐿𝑖] is the free ligand concentration, 𝑠𝑖 is the number
of protein subunits, and 𝑖 is summed over all simulation systems. 𝑘on was calculated
irrespective of the bound pose of the ligand and suggests glutamate binding is not
diffusion controlled since it is 100 times slower than the association rates of typical
diffusion-limited binding processes (e.g., 𝑘on ∼ 109 − 1010 M−1 s−1) [45, 46]. See Ta-
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ble 4.2. Electrostatic steering may play a role in determining the overall association
rates of the ligand to the binding site [47].
4.4.7 Molecular biology.
Point mutations were introduced by overlap PCR and confirmed by double-stranded
sequencing. Numbering refers to the mature polypeptide chain.
4.4.8 Electrophysiology.
WT and mutant glutamate receptors were overexpressed in HEK293 cells using cal-
cium phosphate transfection. The external solution contained: 150 mM NaCl, 0.1 mM
MgCl2, 0.1 mM CaCl2, and 5 mM HEPES, titrated to pH 7.3 with NaOH, to which
we added drugs as required. Drugs were obtained from Ascent Scientific and Sigma.
The pipette solution contained: 115 mM NaCl, 10 mM NaF, 0.5 mM CaCl2, 1 mM
MgCl2, 5 mM Na4BAPTA, 5 mM HEPES and 10 mM Na2ATP (pH 7.3).The sam-
pling rate was 10 kHz (100 𝜇s time step) and during acquisition the data were filtered
at 5 kHz (10-90% rise time 66 𝑚𝑢s). We applied ligands to outside out patches via
a piezo-driven fast perfusion system. Typical 10%-90% solution exchange times were
faster than 300 𝜇s, as measured from junction potentials at the open tip of the patch
pipette. Simulations using realistic concentration jumps were done as described [30]
using a suite of PYTHON scripts (https://github.com/aplested/aligator). The effec-
tive decay constant was back-calculated from the 90âĂŞ10% decay time assuming a
single exponential decay to facilitate comparison. These simulations showed that a
solution exchange of 300 𝜇s reproduces all the observed features of glutamate- acti-
vated AMPA receptor currents, including the approximately 200 𝜇s rise time of wild-
type channels Fig. 4-7.
4.4.9 Functional data analysis.
To measure deactivation and desensitization decay constants, we fitted currents with
a single exponential function. The rise times were measured from the 10-90% crossing
times of a sigmoid function fitted from the baseline to the peak current. We mea-
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sured concentration-response curves for WT and the mutant receptor EKK-AAA. We
obtained the 𝐸𝐶50 and maximum extent of activation relative to glutamate from fits






where 𝑛 is the Hill coefficient, 𝐼max is the maximum response, and [A] is the agonist
concentration.
To measure recovery from desensitization, we used a two-pulse protocol with a
variable interpulse interval. Recovery data were fitted by a Hodgkin- Huxley-type
function [48]
𝑁 = 𝑁0 + (1 −𝑁0)[1 − exp(−𝑘rec𝑡)]𝑛
where 𝑁 is the active fraction of receptors at time 𝑡 following the first pulse, 𝑁0 is the
active fraction at the end of the conditioning pulse, and 𝑘rec is the rate of recovery.
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4.7 Additional trajectory descriptions
Trajectory Tdim2
In Tdim2 , glutamate contacts K449 in Lobe 1 on the anterior surface of the LBD and
then moves towards the binding cleft, sandwiched between K449 and R453. The 𝛼-
carboxyl group transitions away from K449 to contact R485 and temporarily adopts
the crystallographic pose (Fig. 4-3A). Contacts between Lobe 2 and the ligand are
then severed. Subsequently, the entire ligand rotates such that its 𝛾-carboxyl group
now contacts R485, adopting the inverted pose (Fig. 3B); the 𝛼-carboxyl group in-
teracts with S654 in Lobe 2; the amide is coordinated by P478, T480, E705, and a
water molecule. The events of Tdim2 (Fig. 4-9 and Movie S2) suggest interconversion
between poses is possible, at least before the cleft completely closes. It is possible that
an extension of Tdim2 could result in the ligand returning to the crystallographic pose.
In support of this notion, MD simulations of drug binding to G-protein-coupled recep-
tors showed that a drug initially bound in a non-crystallographic pose, it eventually
converted to the crystallographic pose [22]. Interestingly, the extent of cleft closure
on the inverted glutamate is not as great as that seen in Tdim1. It is unknown how
stable the inverted pose is, but this binding mode could effectively cause glutamate
to act as a partial agonist due to a lesser extent of cleft closure.
Trajectories Tdim3 and Tdim4
The trajectories Tdim3 and Tdim4 also result in an inverted pose. Tdim3 resembles
Tdim2 up to the point at which the ligand’s Îş-carboxyl group contacts R453 and the
𝛼-carboxyl group contacts K449. In Tdim3, however, instead of the 𝛼-carboxyl group
contacting R485, which would result in the crystallographic pose, the ligand’s amide
group transitions into the binding cleft to contact E402 on the 𝜉2 side. The 𝛾-carboxyl
group then switches interaction partners from R453 to R485 and settles into its bound
pose. In Tdim4, the ligand diffuses onto the Lobe 2 surface of the binding cleft and
contacts R485 with its 𝛾-carboxyl group. Tdim4 involves no significant metastable
interactions before the ligand assumes its bound pose.
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Trajectory Tmon1
For one of the two ligand-association events that were observed with an LBD monomer,
trajectory Tmon1 , the ligand diffused in bulk solvent for 2.95 𝜇s before binding to the
LBD, presumably because this system contained only one glutamate ligand (effec-
tive concentration of 3.9 mM). Tmon1 initially resembles Tdim1 except that glutamate
binds in the inverted pose (Fig. 4-10 and Movie S3). In Tmon1, the ligand initiates
contact with the LBD by forming a metastable interaction with E657, R660, and
R661 on helix F via its 𝛼-carboxyl group. Its 𝛾-carboxyl group subsequently binds
to the guanidinium group of R485, which, as in Tdim1, has transiently rotated out of
the binding pocket to form the interaction. Helix F releases its hold on the ligand,
which then binds into the binding cleft via the same interactions described for Tdim2.
Trajectory Tmon2
The other association event involving an LBD monomer took place within a system
containing 10 glutamate ligands (effective concentration of 38.9 mM). The binding
pathway very closely resembles Tmon1, with the ligand forming a metastable inter-
action with R660 and R661 on helix F before binding to R485 and docking in the
inverted pose.
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Fig. 4-1: Dynamics of glutamate binding. Time points (lower left of each
panel) are relative to the start of Movie S1. This trajectory corresponds to the LBD
dimer system Tdim1 (see Table 4.1); only the LBD that binds glutamate is shown
for clarity. (a) Prior to ligand entry to the binding pocket, the LBD is open; (𝜉1, 𝜉2)
= (12.3, 12.2 Å). The ligand’s 𝛾-carboxyl contacts R453 on Lobe 1. (b) Close-up
view of (a). (c) Glutamate slips into the binding cleft. (d) The ligand contacts R661
on Lobe 2. (e) A metastable interaction forms across Lobes 1 and 2. The ligand’s
𝛾-carboxyl contacts E657, R660, and R661 on helix F and the ligand’s 𝛼-carboxyl
contacts R485. R485 flickers out of the binding pocket to interact with the ligand.
(f-h) R485 relaxes towards the binding pocket. The metastable interaction at the
ligand’s 𝛼- and 𝛾-carboxyl between Lobes 1 and 2 persists. (i) The ligand shifts
into the binding pocket, with its 𝛼-carboxyl contacting R485. Lobe 2 interactions
with helix F are broken. In the pocket, the ligand’s amide is coordinated by P478
and L480. Cleft closure is initiated once helix F undergoes a backwards tilt to form
a pocket for the ligand’s 𝛾-carboxylate. (j) Glutamate adopts the crystallographic
conformation. (k) The ligand’s amide contacts E705 on Lobe 2. (l) Expanded view of
(k). The LBD closes around the ligand in the crystallographic conformation: (𝜉1, 𝜉2)




Fig. 4-2: Glutamate binding pathways and metastable binding sites. (a)
The PMF calculated from the ligand density using a hard-sphere van der Waals
approximation on a grid spacing of 0.5 Å along the x, y, and z axes contoured to 1.89
kcal mol−1. The primary binding pathways for glutamate are depicted by arrows. (b)
The PMF, contoured to 1.16 kcal mol−1, shows the metastable binding sites, sites
1-3. Site 0 is the site of stable binding. Site 1 is shared by pathways 1 and 2, site 2 is
encountered in pathway 2, and site 3 is encountered in pathway 3. Site 1 spans the two
lobes, involving R453 in Lobe 1, and E657, R660, and R661 in Lobe 2. Site 2 involves
E657, R660, and R661 in Lobe 2. Site 3 involves R675 and R684 in Lobe 2. The
residues involved in Site 0 are shown in panel Fig. 4-3a. Error analysis is provided
in Fig. 4-9. (c) The PMF, contoured at 0.32 kcal mol−1, shows the global free
energy minimum. This minimum overlaps well with the ligand density derived from
crystal structures of the glutamate-bound complex (e.g., PDB ID: 1FTJ). (d) The
one-dimensional representation of the WT GluA2 ligand-binding PMF was obtained
by first computing the three-dimensional PMF (panels a-c). Values of the three-
dimensional PMF were indexed increasing in the 𝑧, 𝑦, then 𝑥 directions, from (𝑥min,
𝑦min, 𝑧min), to produce the one-dimensional representation. The positions of Sites 0-3
are indicated. Site 0 is the global free energy minimum and is set to 0 kcal/mol; Sites
1-3 form local minima with free energies of 0.29, 0.83, and 0.75 kcal/mol, respectively.




Fig. 4-3 Conformations of bound glutamate and the LBD. (a) The bound
ligand conformation, similar to that observed in PDB ID 1FTJ. The ligand’s 𝛼-
carboxylate contacts R485, and its 𝛾-carboxylate contacts the amide backbone of
T655. The ligand’s amide group is coordinated to the sidechains of T480 and E705
and to the backbone of P478. (b) The inverted conformation of the ligand. The
ligand’s 𝛼-carboxylate contacts the backbone amide of S654, and its 𝛾-carboxylate
contacts R485. The ligand’s amide group is coordinated to E705. P478 has moved
upwards to accommodate a water molecule that also contacts the ligand’s amide
group. (c) The two-dimensional order parameter (𝜉1, 𝜉2) used to characterize large-
scale conformational transitions in the GluA2 LBD. 𝜉1 and 𝜉2 each indicate the dis-
tance between the centers-of-mass of the clusters of atoms shown in blue and green,
respectively. (d) (𝜉1, 𝜉2) measures the degree of cleft closure for the LBD in apo
(blue) and ligand-bound conformations. The ligand occupies either the crystallo-
graphic (yellow) or inverted (green) poses. Each point represents a snapshot taken
every 120 ps from simulations of the monomer system at 3.9 mM glutamate concen-
tration. The marginal histograms indicate distribution densities. See also Fig. 4-10




Fig. 4-4: Activation and deactivation of receptors with mutations in Path-
way 1. (a) Sites of mutations that were tested functionally. The green-colored
sidechains correspond to the WT residues. The tan-colored residues contact bound
glutamate directly but were not mutated in the functional tests. (b) Blue circle in-
dicates LBD residues proximal to metastable site 1 (Fig. 4-2b) in Lobe 1. Mutants
tested include single charge swaps R453D and K458D, and the triple mutant R453A
D456A K458A (RDK-AAA). (c) Activation of Lobe 1 mutants (R453D, blue; K458D,
green; RDK-AAA, red) by a long pulse of 10 mM glutamate. Solution exchange
measured after the experiment is shown as the upper black trace. A typical WT
GluA2 response is plotted with a dotted line. The individual 10-90% rise times of
the currents (𝑡rise) are shown in the bar chart in the right panel, with the WT mean
value as a dashed gray line. Asterisk indicates P < 0.005, Student’s 𝑡-test. (d) Left
panel shows deactivation of Lobe 1 mutants in response to ∼1 ms pulse of 10 mM
glutamate. Color coding is as in (c), with monoexponential fits indicated by open
circles. Right panel shows bar chart of individual deactivation decay values. Asterisk





Fig. 4-5 Activation and deactivation of receptors with mutations in Path-
ways 1 and 2. (a) Residues in Lobe 2 that interact with the ligand at metastable
sites 1 and 2 (Fig. 4-2b) included R660E, R661E and E657A R660A R661A (ERR-
AAA). (b) Left panel shows activation of Lobe 2 mutants (R660E, green; R661, blue;
ERR-AAA, red) in response to a long pulse of 10 mM glutamate. The individual
10-90% rise times of the currents (𝑡rise) are shown in the bar chart in the right panel,
with the WT mean value as a dashed gray line, with asterisk indicating P < 0.05
vs. WT from 𝑡-test. (c) Left panel shows deactivation of Lobe 2 mutants following
a 1 ms pulse of 10 mM glutamate, with color coding as in (b). Individual rise times
are plotted in the right panel. (d) The affinity for glutamate is unchanged for the
ERR-AAA mutant relative to WT. Dose-response curves in glutamate, measured at
the peak current response, for WT GluA2 (𝐸𝐶50 = 330 ± 90 𝜇M; black circles),
and for the mutant ERR-AAA (𝐸𝐶50 = 410 ± 30 𝜇M, red circles). By comparing
the fits to responses from individual cells, the glutamate 𝐸𝐶50 for ERR-AAA was
indistinguishable from that of WT GluA2 (p = 0.5; 𝑡-test, 𝑛 = 3). (e) The PMF for
the ERR-AAA mutant, contoured at 2.62 kcal/mol, shows a loss of ligand density
along Pathways 1 and 2, proximal to helix F. The ERR-AAA ligand-binding path-
way, indicated by the red arrow, resembles Pathway 3 of the WT LBD. Interactions
between R684 and R675 on Lobe 2 at site 4 are preserved in both the mutant and
WT protein. These residues metastably interact with the ligand prior to binding in




Fig. 4-6: Activation and deactivation of receptors with mutations in path-
way 3 and off-pathway mutants. (a) Blue circles indicate residues in Lobe 1 of
the LBD that participate in transferring the ligand from metastable site 3 to site 0
(Fig. 4-2b; D447, K449) and that were mutated to alanine (DK-AA). In Lobe 2,
two residues that participate in site 3 (R684, E688) were separately mutated to ala-
nine (RE-AA). (b) The activation of receptors in response to a long pulse of 10 mM
glutamate were slower than WT GluA2 (dashed line) for both DK-AA (blue trace)
and RE-AA (red trace). The upper black trace shows solution exchange. Individual
10-90% rise times are plotted in the right panel with the mean value for WT GluA2
indicated by a dashed line and standard error shaded in light gray. Asterisks indicate
P < 0.01 vs. WT GluA2, 𝑡-test, 𝑛 = 3-6. (c) Deactivation of DK-AA and RE-AA
mutants in response to a 1 ms pulse of 10 mM glutamate with color-coding as in (b).
Monoexponential fits are represented by open circles. Individual deactivation decay
constants are plotted in the bar graph (right panel). The asterisk indicates P < 0.05
vs. WT GluA2, 𝑡-test, 𝑛 = 3-6. (d) Blue circles indicate positions in the LBD of two
triple-alanine mutants, located away from the binding pathways (Fig. 4-2a). One set
of off- pathway mutants was located in Lobe 1 (K409A, K410A, E422A; KKE-AAA)
and one set in Lobe 2 (R715A, K716A, D769A; RKD-AAA), (Fig. 4-4a). (e) Left
panel shows activation of receptors by long pulses of 10 mM glutamate. Responses
for the KKE-AAA (blue trace) and RKD-AAA (green trace) mutants are overlaid
with a typical WT GluA2 response as in (c), with individual rise times plotted in
the right panel. Asterisk indicates P < 0.05. (f) Left panel shows deactivation of
off-pathway mutants following a 1 ms pulse of 10 mM glutamate. Color coding as in
(e). Individual rise times are plotted in the right panel. Asterisk indicates P < 0.01.




Fig. 4-7: Kinetic modeling of AMPA receptor currents activated by glu-
tamate recapitulates the effect of slowed binding reactions on receptor
activation and deactivation. (a) Kinetic model constructed according to prin-
ciples outlined in previous studies of GluA2 kinetics [29]. Four glutamate binding
sites, two open states (green, *) and five desensitized states (red) are included. Low
conductance open states and connections between desensitized states were omitted
for simplicity. For each simulation, the association and dissociation rates were multi-
plied by a common factor, 𝑓 , to represent the effects of mutants to slow binding rates
through disruption of glutamate binding pathways. The rate constants were as fol-
lows: beta = 5000 s−1, alpha = 3000 s−1, 𝑘+ = 5 × 106 M−1 s−1, k- = 10000 s−1 , 𝑑+
= 250 s−1, 𝑑- = 60 s−1 , 𝑑0+ = 1 s−1 , 𝑑0- = 9 s−1 . The conductance of the open state
A4R* was set at twice that of A3R*. (b) Example simulated currents (normalized to
the maximum possible response) for a realistic concentration jump of 800 𝜇s with rise
time of 300 𝜇s, using the model in panel a. Six color-coded current profiles generated
using the RCJ scripts (see Methods) are shown, with the binding rate factor rang-
ing from 2 to 0.05. Note that deactivation is more strongly affected than activation
(because efficacy for channel opening is > 1). Also, for fast binding reactions, the
rise time is faster than the solution exchange. (c) Kinetic measurements from GluA2
mutants and wild-type (black circles, WT GluA2 marked) were well described by a
linear fit with slope of ∼8 with intercept close to the origin. 95% confidence intervals
for the line are shown as grey dashed curves. Uncertainties in both abscissa and
ordinate were used for the fit (ODR 2 in Igor 7). Off-pathway control mutants (red
circles) lie away from this curve. Data from simulations with different rise times for
the glutamate pulse are plotted as open symbols, with the relevant f value for each
group of simulations indicated with a dotted line. The colors of these symbols re-
lates to the simulated 10-90% solution exchange time seen by receptors. All solution
exchange rates predict the similar steep, approximately linear relations between acti-
vation time (10-90%) and decay time constant. The simulated kinetics span a similar
range to the electrophysiological recordings of pathway-disruption mutants. The best
agreement between simulation and experiment comes from solution exchange times
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Fig. 4-8 Sites of metastable protein-ligand interactions. (a) Sequence align-
ment of iGluR LBDs across AMPA, kainate, and NMDA receptors in rat. Binding
pocket residues are boxed in red. Residues that make metastable interactions are
boxed in yellow. Off-pathway residues that were mutated are boxed in black. (b)
Sites of mutation in a tetrameric GluA2 receptor. Each sphere corresponds to a site
of mutation shown in Fig. 4-4a in a tetrameric receptor. R453, D456, and K458 are
in red; E657, R660, and R661 are in magenta; D447 and K449 are in yellow; R684
and E688 are in green; K409, K410, and E422 are in blue; R715, K716, and D769 are
in violet. The mutations occur in all subunits of the receptor, but they are shown in




Fig. 4-9 Error analysis of the ligand density PMF. Related to Figure 2. (a-
f) The 3D PMF (blue) is shown at contour levels ranging from 0.6 kcal/mol to 3.6
kcal/mol in increments of 0.6 kcal/mol. (g-l) The statistical uncertainty in the 3D
PMF determined using the approach of block averaging. 10 blocks were used. Con-
tours of the 3D standard deviation (red) are shown from 0.2 kcal/mol to 1.2 kcal/mol
in increments of 0.2 kcal/mol. Protein-ligand interactions (a-d) have uncertainties
ranging from approximately ±0.8 to ±1.2 kcal/mol (g-l), whereas sites in bulk sol-




Fig. 4-10: Glutamate binding in the inverted conformation. Time points
(lower left of each panel) are relative to the start of Movie S2. (a) Prior to ligand
binding, the LBD is closed; (𝜉1, 𝜉2) = (11.0, 11.7 Å). The ligand’s 𝛾-carboxylate
contacts R660. (b) Close-up view of (a). (c-d) The ligand moves away from R485 as
it is passed from R660 to R661. Interactions between the ligand and helix F residues
switch from the 𝛾-carboxylate at R660 to the 𝛼-carboxylate at R661. (e) The LBD
opens, (𝜉1, 𝜉2) = (15.0, 11.2 Å), to allow ligand entry into the binding pocket. (f-g)
The ligand metastably bridges Lobes 1 and 2 as its 𝛼-carboxylate contacts R485. (h)
Interactions with helix F residues are broken, and the ligand moves into the binding
pocket, tethered to R485. (i) Glutamate adopts the inverted bound conformation.
(j-k) The ligand’s amide contacts E705. A hydrogen bonding network is formed
involving P478, a water molecule, and the ligand’s amide, stabilizing the inverted
conformation. (l) Expanded view of (k). The LBD remains slightly open around the





Fig. 4-11: Interconversion between bound ligand conformations. Time
points (lower left of each panel) are relative to the start of Movie S3. (a) Initially,
the ligand binds in the crystallographic conformation. (b) Close-up view of (a); the
ligand’s 𝛼-carboxylate contacts R485, whereas the amide is coordinated by P478 and
E705. (c-d) The 𝛾-carboxylate swings out of the binding pocket to contact R453.
Interactions between the ligand’s amide with P478 and E705 are broken. (e-f) The
𝛾-carboxylate rotates freely in the binding cleft while the 𝛼-carboxylate remains teth-
ered to R485. (g) Contacts between the 𝛼-carboxylate and R485 are severed as the
ligand repositions. (h) The 𝛾-carboxylate of the ligand contacts R485. (i) The ligand
swings into the binding pocket. (j) Glutamate adopts the inverted bound conforma-
tion. (k) The ligand’s amide contacts E705, and P478 forms a hydrogen bond with a
water molecule that stabilizes the inverted conformation. (l) Expanded view of (k).




Fig. 4-12: Slower activation and deactivation are retained in high gluta-
mate. (a) Normalized current responses corresponding to activation by a long pulse
of 50 mM glutamate are shown for the RDK-AAA mutant (red) with WT GluA2
(dashed black trace). The upper trace shows the application of glutamate. Rise
times (10-90%) from individual patches are shown in the bar graph (right panel). (p
= 0.01 vs. WT; 𝑡-test, 𝑛 = 3). (b) Monoexponential decays for WT GluA2 (dashed
black line) and RDK-AAA (red line) were fitted for the deactivation in response to
a 1 ms pulse of 50 mM glutamate (open circles). The upper trace shows the open
tip response. Deactivation time constants from individual patches are plotted in the
bar graph (right panel; p = 0.0003; 𝑡-test, 𝑛 = 3). (c) Desensitization time constants
were not altered by the RDK-AAA mutant. Monoexponential fits as in (b). Desensi-
tization time constants from individual patches plotted in the bar graph (right panel)




Fig. 4-13: Desensitization and recovery from desensitization of receptors
mutated at metastable sites 1 and 2. (a) Monoexponential fits to desensitization
decays of R453D, K458D and the R453D, D456A, K458A (RDK-AAA) mutants in
response to 10 mM glutamate were similar to WT (p > 0.03; 𝑡-test, 𝑛 = 3 - 7). A
typical WT GluA2 response is shown as a dashed line. Decay constants for individual
patches are plotted in the right panel, with the average value for WT GluA2 indicated
by a black dashed line, with standard error shaded in light grey. (b) As for (a),
but for the R660E, R661E and E657A, R660A, R661A triple mutants. Fits were
similar to that of WT (p > 0.2; 𝑡-test, 𝑛 = 3). (c) Left panels show fits to pooled
responses ("Active Fraction") at increasing intervals after a long pulse of 10 mM
glutamate for WT and the different mutants. The R453D and RDK-AAA mutants
recovered from desensitization about twice as fast as WT (p < 0.02; 𝑡-test, 𝑛 =
3). Recovery time constants for individual patches, with the WT mean value and
standard error indicated as in (a-b). (d) Recovery data for the R660E, R661E and
ERR-AAA mutants presented as in (c). Recovery time constants for these mutants
were not significantly different from that of WT (p > 0.1; 𝑡-test, 𝑛 = 3).
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Fig. 4-14: Desensitization and recovery from desensitization of receptors
with mutations in pathway 3 and in off-pathway regions. (a) Monoexponential
fits to desensitization decays of DK-AA (D447A K449A) and RE-AA (R684A, E688A)
mutants in response to 10 mM glutamate were similar to WT (p = 0.03 for DK-AA,
p = 0.8 for RE-AA; 𝑡-test, 𝑛 = 3 - 7). Fits are represented by open circles. A typical
WT GluA2 response is overlaid (black dashed line). Decay constants for individual
patches are plotted in the right panel, with the average value for WT GluA2 indicated
by a black dotted line, with its standard error shaded in light grey. (b) As for (a),
but for the KKE-AAA and RKD-AAA control mutants (P = 0.7 and 0.4 vs. WT,
respectively; 𝑡-test). (c) Left panels show fits to pooled responses ("Active Fraction")
at increasing intervals after a long pulse of 10 mM glutamate for WT and the DK-AA
and RE-AA mutants. The RE-AA mutant gave very small currents recovered from
desensitization about four times as fast as WT (p = 0.008; 𝑡-test, 𝑛 = 3 - 5). Recovery
time constants for individual patches, with the WT mean value and standard error
indicated as in (a-b). (d) Recovery data for the KKE-AAA and RKD-AAA mutants
(P = 0.6 and 0.01 vs. WT, respectively; 𝑡-test), presented as in (c).
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Table 4.1: Ligand-binding trajectories for the dimer and monomer systems.
a Binding events are labeled A for association and D for dissociation
b 𝜇s in the apo conformation prior to the binding event
c 𝜇s in the docked ligand conformation
d units are in Ångstroms
e 𝜇s in the apo conformation after the binding event
127






, where 𝑁𝑏 is the total number of binding events; 𝑡𝑖 is the time the
ligand spends in bulk solvent, [𝐿𝑖] is the free ligand concentration, 𝑠𝑖 is the number
of protein subunits, and 𝑖 is summed over all simulation systems.
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Table 4.3: Kinetic properties of WT GluA2 and mutants. All experiments
were done with 10 mM glutamate except where noted. The number of experiments is
indicated in brackets. 𝑡10−90%rise, rise time; 𝜏deact, time constant from single exponen-
tial fits to the deactivation decay; 𝜏des, time constant from single exponential fits to
the desensitization decay; 𝜏rec, recovery time constant from Hodgkin-Huxley fits with
ℎ = 2 (see Materials and Methods). 𝑃 values are from two-tailed Student’s 𝑡-test
against WT values.
129
Table 4.4: Ligand-binding trajectories for the ERR-AAA mutant LBD.
a Binding events are labeled A for association and D for dissociation
b 𝜇s in the apo conformation prior to the binding event
c 𝜇s in the docked ligand conformation
d units are in Ångstroms
e 𝜇s in the apo conformation after the binding event
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Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that are
responsible for the majority of excitatory transmission at the synaptic cleft. Me-
chanically speaking, agonist binding to the ligand binding domain (LBD) activates
the receptor by triggering a conformational change that is transmitted to the trans-
membrane region, opening the ion channel pore. We use fully atomistic molecular
dynamics simulations to investigate the binding process in the AMPA receptor, an
iGluR subtype. The string method with swarms of trajectories was applied to cal-
culate the possible pathways glutamate traverses during ligand binding. Residues
peripheral to the binding cleft are found to metastably bind the ligand prior to lig-
and entry into the binding pocket. Umbrella sampling simulations were performed
to compute the free energy barriers along the binding pathways. The calculated free
energy profiles demonstrate that metastable interactions contribute substantially to
the energetics of ligand binding and form local minima in the overall free energy land-
scape. Protein ligand interactions at sites outside of the orthosteric agonist-binding
site may serve to lower the transition barriers of the binding process.
5.1 Background
In the brain, glutamate binding serves as an essential signal for activation of down-
stream neurons [1]. AMPA receptors, composed of an amino-terminal domain (ATD),
a ligand binding domain (LBD), a transmembrane domain (TMD) and C-terminal
domain (CTD), sense the release of neurotransmitters at synaptic terminals [2]. Archi-
tecturally, AMPA receptors are tetrameric complexes arranged in a dimer-of-dimers
fashion [3]. The binding of neurotransmitters triggers large structural rearrangements
in which conformational change in the separate LBDs provides the necessary tension
for opening the channel pore. Isolated LBDs close once glutamate binds. Thus, ligand
binding and LBD closure are thought to be tightly coupled processes.
Many computational methods have been employed to study protein ligand binding.
Unbiased simulation [4, 5] is the most straightforward approach and yields detailed
information on the molecular mechanisms of the binding process, but it is also the
most computationally expensive, often requiring the use of special purpose hardware
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[6]. Usually, because of the computational cost involved, only a limited number of
binding events are sampled. Enhanced sampling methods, such as umbrella sampling
and the string method, are an alternative approach.
For the AMPA receptor subtype, GluA2, umbrella sampling has been used to
calculate the free energy of ligand binding for multiple agonists [7]. The energetics of
cleft closure and ligand docking were evaluated separately. The contributions to the
free energy from each was computed along a predetermined pathway, using biasing
potentials to pull the system from a ligand free, open LBD conformation to a ligand
bound, closed LBD conformation.
Here, we aim to re-examine glutamate receptor ligand binding using the string
method [8, 9]. In contrast to our previous study [7], translation of the ligand into
the binding pocket is not restricted to a predetermined path, and ligand translation
and protein conformational change are studied as coupled processes in concert. As a
result, we find ligand-binding pathways that are physically more realistic and putative
protein-ligand interactions that occur outside of the binding pocket.
5.2 Computational Modeling and Methods
5.2.1 Simulation System Preparation.
The atomic model for the ligand bound monomer was constructed from the crystal
structure of the GluA2 ligand-binding core (S1S2) in complex with glutamate (PDB
ID: 1FTJ). The atomic model for the ligand free monomer was constructed from the
crystal structure of the GluA2 ligand-binding core (S1S2) in the apo state (PDB ID:
1FTO). Missing amino acid residues backbones were added to the model using the
Modloop server [10], and missing sidechains were constructed using SCWRL4 [11].
Models included the crystallographic waters from the binding cleft, and both systems
were solvated with 13,836 water molecules. A glutamate molecule was added to bulk
solvent in the apo system ∼38 Å away from the LBD center of mass. Both sys-
tems were neutralized by adding Na+ and Cl− ions to the bulk solution until the salt
concentration reached 150 mM. Both systems contained a total of 45,723 atoms. Pe-
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riodic boundary conditions were imposed on an orthorhombic cell with approximate
dimensions of 84 Å × 68 Å × 78 Å. The systems were energy minimized and equili-
brated at constant pressure and temperature (NPT) conditions at 1 atm and 300K
with a time step of 2 fs. For all simulations, the all-atom potential energy function
PARAM27 [12,13] for proteins and the TIP3P potential energy function for water [14]
were used. Electrostatic interactions were computing using the particle mesh Ewald
(PME) algorithm and short-range, non-bonded interactions were truncated at 12 Å.
All productions runs were performed in CHARMM [15].
5.2.2 String Method Calculation.
Conformational transitions in biological macromolecules are multi-dimensional pro-
cesses that require the concerted movement along a large number of degrees of free-
dom. The important order parameters that well describe these transitions are often
not known a priori. The string method is a "chain-of-states" approach that opti-
mizes the transition states between two end points and has been used to characterize
conformational change in tyrosine kinases, ion channels, and motor proteins [16–19].
Briefly, the string method interpolates between two end states by sampling states
intermediate to the transition [8, 9]. The algorithm consists of first constructing an
initial interpolation between the two end states to form a transition pathway. The
pathway is then iteratively refined as follows until it converges: (1) each transition
state is evolved using molecular dynamics simulations to estimate the instantaneous
forces underlying the transition; (2) states are moved in the direction of those forces;
(3) the entire pathway is reparametrized to maintain some metric to separate the
states - typically this metric is taken to be the Euclidean distance in the space of col-
lective variables. The two end states used in our study were taken from the prepared
atomic models of the ligand-bound and ligand-free LBD monomers.
Three initial transition pathways were constructed based on the accessibility of
the ligand to the binding pocket. In the interpolation for pathway 1, the ligand was
translated into the binding cleft between K449 and S652 using biasing potentials. For
the interpolations in pathways 2 and 3, glutamate was translated into the binding
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pocket via the 𝜉1 and 𝜉2 sides of the cleft respectively, where 𝜉1 and 𝜉2 are two center
of mass distances between lobe 1 and lobe 2 (Fig. 5-1), using biasing potentials.
The total number of states or images for pathways 1, 2, and 3 were 129, 132 and
129, respectively. For the string method calculations our collective variable was the
Cartesian coordinates of all C𝛼 atoms of the LBD, and the two terminal carbonyl
carbons and the C𝛼 atom of the ligand.
The string method algorithm with swarms of trajectories [9] was applied to all
three pathways. Pathways 1 and 2 converged after ∼225 ns of aggregate sampling.
Pathway 3, however, did not converge after 258 ns of sampling and was discarded for
possibly being pathological. Timesteps of 2.0 fs and 1.0 fs were used in the free and
restrained simulations, respectively. Each iteration of the string method involved the
following: (1) 5,000 steps of restrained dynamics to push the pathway to the target
collective variable values; (2) a short restrained dynamics run for 500 steps to generate
the starting coordinates for the swarms; starting coordinates were written out at 5
step intervals; (3) 100 simulations of short 50-step unbiased simulations to measure
the average drift of the swarms; (4) the average drift was measured, and the positions
of the images were updated using the average drift; (5) the path was reparameterized,
and the target collective variables were updated for the next iteration with the current
position of the images. Convergence of the transition paths were assessed by summing
the distances between the images at the 𝑗-th iteration and the images at the (𝑗 + 1)




(𝜃𝑖,𝑗 − 𝜃𝑖,𝑗+1)2, where 𝜃𝑖,𝑗 is a multi-dimensional vector
representing the collective variables of image 𝑖 at the 𝑗-th iteration.
5.2.3 The Free Energies of the Transition Paths.
Once a pathway is found, part of the difficulty in capturing the free energy along a
particular binding pathway stems from the high dimensionality of the ligand bind-
ing process. Protein-ligand interactions, ligand orientation, protein conformational
change, and specific residue-residue contacts may each contribute to the free energy
along different degrees of freedom [20]. To address this issue, we use umbrella sam-
pling and choose a global order parameter, 𝛼, that measures the progress along the
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binding process. In the discrete case, as in our present study, 𝛼 is an index over the
states of the system 6defined by the transition states of a converged pathway identi-
fied by the string method. Ligand association can then be represented as a transition:
𝛼𝑁 → 𝛼𝑁−1 → · · · → 𝛼1 → 𝛼0; where 𝛼𝑁 corresponds to an initial state containing
the protein and ligand separated by bulk solvent, and 𝛼0 corresponds to a final state
containing the ligand bound complex.
The parameter 𝛼 may depend on many degrees of freedom that capture the confor-
mation of the protein and ligand at the particular transition state of interest. Given
the atomic coordinates of a protein-ligand system, how do we determine 𝛼 and how
far along the binding process a system is? In the present study, we compare the Carte-
sian coordinates of the C𝛼 atoms in the protein to capture the protein conformation
and residue specific interactions, and two terminal carbonyl carbons as well as the
C𝛼 atom in the ligand to specify ligand orientation and protein-ligand interactions.
The system is then assigned to the most similar state, 𝛼𝑖, along the 1-dimensional
transition pathway. This is done automatically by first measuring the coordinates
of interest at each 𝛼𝑖, Voronoi tessellating the phase space of those coordinates, and
assigning each conformation in the neighborhood of 𝛼𝑖 to the index 𝑖.
The free energy along the binding pathway can then be calculated by umbrella
sampling. Voronoi tessellation has been previously used to separate the transition
states [21–23]. Here, the same approach is taken, and statistics on the occupancies of
each state are collected on a confined region of the 1-dimensional pathway through
the use of biasing potentials. The biasing potentials restrain the system along the
multi-dimensional coordinates of interest. Contributions of the biasing potential to
the free energy can be unbiased using the Weighted Histogram Analysis Method
(WHAM) [24, 25]. Thus, the method calculates a free energy profile across a multi-
dimensional surface. The accuracy of this PMF depends on the degree of sampling
between each state, 𝛼𝑖, and its neighbors.
Umbrella sampling simulations, totaling 105 ns along pathway 1 and 103 ns along
pathway 2, were performed to calculate the free energy profiles. Each image was har-
monically restrained with force constants (0.01 kcal/mol/Å2) at each of the collective
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variables from the string method. Biased distributions were collected across all col-
lective variables. The phase space of the collective variables was voronoi tessellated,
using each image as the center for the voronoi cell. The biased distribution of states
along the binding pathway was calculated by assigning systems in the neighborhood
of state 𝑖 to state 𝑖 based on the voronoi tessellation, i.e.,
𝑥 ∈ 𝛼𝑖 ↔ ‖𝜃(𝑥) − 𝜃(𝛼𝑗)‖ ≥ ‖𝜃(𝑥) − 𝜃(𝛼𝑖)‖, ∀𝑗 ̸= 𝑖
where x represents a conformation of the system collected during the umbrella sam-
pling, 𝛼𝑖 is the system at image index 𝑖, and 𝜃(𝑥) is a multidimensional vector con-
taining the collective variable values of conformation 𝑥. The biased distributions were
unbiased using WHAM.
5.3 Results and Discussion
5.3.1 Local optimization of metastable binding intermediates.
Binding along converged pathways 1 and 2 contains distinct interactions with residues
on the periphery of the LBD cleft that are not directly in the binding pocket. The
presence of multiple binding pathways suggests that ligand binding is not restricted
to a single pathway. In pathway 1, the ligand forms interactions with R453 and
R661, whereas in pathway 2, the ligand forms interactions with R684 and K449. In
particular, R453 and R684 pass the ligand to R660 and K449, respectively, prior to
binding. R660 and K449 form metastable interactions with the ligand before passing
it into the pocket (Fig. 5-2 C-E; Fig. 5-3 C-E). Once inside the pocket, the ligand
contacts Y450 and R485 on lobe 1, and E705 on lobe 2, as the LBD closes.
Certain residues were observed to be involved in locking the LBD closed. A salt
bridge between K730 and D728 in the hinge region of the LBD forms after the ligand
settles into the binding pocket. The interaction between K730 and D728 may be
correlated with the degree of cleft closure. This salt bridge forms once the LBD is
closed to (𝜉1, 𝜉2) = (11.9, 11.4 Å) in pathway 1 and to (𝜉1, 𝜉2) = (9.5, 5.3 Å) in pathway
2. Previous crystallographic experiments showed K730 forms a salt bridge with E705
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in the apo state; however, when a ligand is bound, K730 switches interaction partners
to D728 [26]. Also consistent with the crystal structures, the D651-S652 peptide bond
flips to form additional hydrogen bonding interactions between lobe 1 and lobe 2 of
the LBD; the backbone carbonyl group of S652 (lobe 2) hydrogen bonds with the
backbone amide of G451 (lobe 1).
5.3.2 Characterizing the energetics of molecular interactions
along a binding pathway.
We computed the free energy profile along each of the converged binding pathways
obtained with the string method. In pathway 1 (Fig. 5-4), the free energy plateaus
when the protein and ligand are separated by ∼12 Å of solvent (𝑖 = 90) and oscillates
around 7-8 kcal/mol as the electrostatic effects attracting the negatively charged
ligand and positive residues in the binding cleft decay. Contact between the ligand
and specific residues on the periphery of the binding cleft lower this free energy
barrier. R684 contacts the ligand’s 𝛼-carboxylate (𝑖 = 73), lowering the free energy
by ∼2 kcal/mol, and the S652 side chain hydrogen bonds with the ligand (𝑖 = 61),
lowering the free energy by ∼1 kcal/mol. Notably, K449 contacts the ligand (𝑖 =
50) and passes it into the binding pocket. As the ligand enters from the 𝜉1 side of
the binding cleft, it interacts with three separate residues that stabilize a metastable
transition state in which (1) the ligand’s 𝛼- carboxylate coordinates the amide group
of Y450, (2) the ligand’s amide group interacts with the hydroxyl side chain of S652,
and (3) the ligand’s 𝛾-carboxylate contacts K449 (𝑖 =32). This metastable interaction
decreases the free energy barrier by ∼3 kcal/mol. The 𝛼-carboxylate shifts into the
binding pocket to contact R485 (𝑖 =27), whereas the 𝛾-carboxylate rotates downward
to contact S654 and T655 (𝑖 = 13). Interactions that lock the LBD closed, including
lobe 1 - lobe 2 interactions between S652 and G451 (𝑖 = 24) and the salt bridge
between K730 and D728 in the hinge region (𝑖 = 14), raise the free energy by ∼2
kcal/mol.
Similarly in pathway 2 (Fig. 5-5), attractive protein ligand interactions plateau at
∼10 Å (𝑖 = 102). The ligand first contacts the LBD at R453 on the 𝜉1 side, lowering
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the free energy barrier by ∼5 kcal/mol. R661 contacts the 𝛾-carboxylate (𝑖 = 29),
decreasing the free energy by ∼6 kcal/mol. R485 rotates out of the binding pocket
via rotations of +130, +20, -124, and -61 around the R485 sidechain’s 𝜒1, 𝜒2, 𝜒3, and
𝜒4 torsion angles, respectively (Fig. 5-5 F, K) to coordinate the 𝛾-carboxylate (𝑖 =
17). Glutamate moves into the binding pocket while its 𝛾- carboxylate is coordinated
by R485, and then flips downward so that the 𝛾-carboxylate contacts S654, whereas
the 𝛼-carboxylate flips up to contact R485 (𝑖 = 13). The LBD locks closed as the
D651-S652 peptide bond flips (𝑖 = 13) and the K730-D728 salt bridge forms (𝑖 =
8). These interactions that close the LBD do not raise the free energy as in pathway
1; however, the final ligand-bound complex (𝑖 = 0) increases the free energy by ∼3
kcal/mol.
The total binding free energy is given by: ∆𝐺bind = ∆𝐺0 +∆𝐺𝑁 +
∑︀𝑁−1
𝑖=0 ∆𝐺𝑖,𝑖+1,
where ∆𝐺𝑖,𝑖+1 is the relative free energy difference between the system at state 𝑖
and state 𝑖 + 1. ∆𝐺0 is the free energy difference between the initial state and the
unbiased ensemble of bound protein- ligand conformations. ∆𝐺𝑁 , likewise, is the free
energy difference between the final state and the unbiased ensemble of apo protein and
free ligand conformations. Assuming the initial (𝑖 = 0) and final (𝑖 = N) states of the
binding pathway are well sampled, ∆𝐺0 and ∆𝐺𝑁 may be small. Alternatively, ∆𝐺0
and ∆𝐺𝑁 may be calculated by methods that estimate the free energy of restraining
the orientational, conformational, and translational change in both the protein and
ligand during binding [7].
The overall free energy difference between the initial and final state,
∑︀𝑁−1
𝑖=0 ∆𝐺𝑖,𝑖+1,
is -5.8 kcal/mol in pathway 1 and -8.8 kcal/mol in pathway 2, close to the experimen-
tally measured binding free energy of -8.3 kcal/mol (IC 50 ) derived from competition
assays of radiolabeled AMPA with glutamate [26]. Discrepancies in the calculated free
energy values may be due to differences in the initial and final protein-ligand confor-
mations between the two pathways, undersampling of state-to-state transitions, and
inherent difficulties of free energy estimation in high dimensional spaces. The free en-
ergy difference between the end points may be compared to the experimental binding
free energies if these discrepancies are small and the end points are representative of
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the ligand bound and ligand free ensembles.
5.4 Conclusions
In the present study, we have utilized a "chain-of-states" approach to probe glutamate
binding in the AMPA receptor. The binding pathways converged after a few hundred
nanoseconds of simulation time, whereas unbiased simulations typically require simu-
lation times on the order of tens of microseconds to sample binding events in proteins
which have similar on rates (𝑘on ∼ 107 M−1s−1) [5]. Metastable interactions between
the ligand and positively charged residues on helix F (R660, R661), R684, K660, and
R453 lower the free energy barrier during ligand binding, and form local minima in
the free energy landscape. The converged glutamate binding pathways indicate that
the ligand binds either via the 𝜉1 side of the LBD or the space formed between K449
and S652.
The string method approach has several limitations. Most notably, because the al-
gorithm only moves images down an energy gradient, intermediate states can fall into
local minima and become "trapped", requiring several different initial interpolations
to sample multiple transition pathways. It is difficult to sample all possible transi-
tion pathways using the string method, and other low energy pathways for glutamate
binding may exist, distinct from the two observed pathways.
Free energy profiles calculated along the binding pathways demonstrate that spe-
cific residue- ligand interactions outside of the binding pocket contribute substantially
to the energetics of ligand binding. Why might a protein domain contain such low
affinity binding sites that do not engage the ligand in its stably bound form? We
speculate that these interactions may serve to position the ligand into conformations
that are more competent to bind. If this is true, metastable binding sites can fa-
cilitate the diffusion of ligands across narrow, tight spaces, like the recessed binding
pocket of the AMPA receptor LBD. In general, proteins have adopted a wide range
of strategies to transfer molecules to locations where they can be acted upon, so it
is not implausible that low affinity binding sites situated in strategically positioned
locations may be another general feature for molecular transport.
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Fig. 5-1: Opening and closing of the GluA2 LBD is described by the two-
dimensional order parameter (𝜉1, 𝜉2). 𝜉1 and 𝜉2 each indicate the center-of-mass
distance between the atoms shown in green and cyan, respectively.
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Fig. 5-2 Locally optimized binding intermediates in pathway 1. (A) The
initial conformation used in the string method for pathway 1 contains an open LBD
(𝜉1, 𝜉2) = (14.1 Å, 13.9 Å) and a ligand separated by bulk solvent. (B) Close-up view
of (A). (C) Glutamate contacts R684 on lobe 2. (D) The S652 hydroxyl sidechain
hydrogen bonds with the amide nitrogen of glutamate. (E) K449 interacts with the
ligand’s 𝛾-carboxyl (F) Glutamate shifts into the binding pocket. (G) Glutamate
forms thee contacts across lobe 1 and lobe 2 of the LBD: (1) The 𝛼-carboxyl contacts
the amide backbone of Y450. (2) The amide nitrogen interacts with the S652 hydroxyl
side chain. (3) K449 contacts the 𝛾-carboxyl. (H) Glutamate is coordinated by the
aromatic sidechain of Y450, aligning with the 𝛼-carboxyl proximal to R485. (I) The
𝛼-carboxyl contacts R485 on lobe 1 and E705 on lobe 2. (J-K) The LBD closes
further around the ligand (𝜉1, 𝜉2) = (9.5 Å, 8.3 Å) as the 𝛾-carboxyl contacts the




Fig. 5-3 Locally optimized binding intermediates in pathway 2. (A) The
initial conformation used in the string method for pathway 2 contains an open LBD
(𝜉1, 𝜉2) = (14.1 Å, 13.9 Å) and a ligand separated by bulk solvent. (B) Close-up view
of (A). (C-D) Glutamate contacts R453 on the 𝜉1 side of lobe 1. (E) R661 contacts
the ligand’s 𝛾-carboxyl (F) R485 flickers out of the binding pocket to contact the
𝛾-carboxyl. (G-I) R485 relaxes toward the binding pocket while coordinating the
ligand’s 𝛾-carboxyl. (J) The 𝛾-carboxyl flips downward into the binding pocket, while
the 𝛼-carboxyl flips upward to contact R485. The amide nitrogen contacts E705 on
lobe 2. (K) The LBD closes further around the ligand (𝜉1, 𝜉2) = (9.5 Å, 8.3 Å) as the





Fig. 5-4: The free energy profile along binding pathway 1. The indices refer
to images or conformations along pathway 1, calculated by the string method. The
free energy was calculated by voronoi tessellating the phase space of the collective
variables and performing umbrella sampling. At images (𝑖 = 90 - 129) the ligand is
in bulk solvent, and at image 0, the ligand is fully bound within the LBD, in the
crystallographic conformation. Protein-ligand interactions that change the energetics
of ligand binding are labeled. The asterisk (*) indicates an image that contains a
metastable intermediate consisting of the following interactions: ligand 𝛼-carboxyl
to Y450 amide backbone, ligand amide to S652 hydroxyl side chain, and ligand 𝛾-
carboxyl to K449 sidechain.
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Fig. 5-5: The free energy profile along binding pathway 2. The indices refer
to images or conformations along pathway 2, calculated by the string method. The
free energy was calculated by voronoi tessellating the phase space of the collective
variables and performing umbrella sampling. At images (𝑖 = 102âĂŞ131) the ligand
is in bulk solvent, and at image 0, the ligand is fully bound within the LBD, in the
crystallographic conformation. Protein-ligand interactions that change the energetics
of ligand binding are labeled.
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Chapter 6 - Concluding Remarks
There are many unanswered questions regarding ionotropic glutamate receptor be-
havior. In this dissertation, we have focused on understanding two parts of iGluR
activation - ligand binding, and LBD conformational change. In Chapter 2, we out-
lined the umbrella sampling free energy method we used to understand the energetics
of these processes. Chapter 3 examined the free energy landscapes of conforma-
tional change in a particularly high affinity glycine binding domain. Chapter 4
identified metastable binding sites which funnel the ligand into the binding pocket
and presented molecular simulations of ligand binding in iGluRs. Chapter 5 uncov-
ered multiple possible ligand binding pathways and examined the energetics of those
pathways.
Notably lacking in these studies, is a rigorous understanding of the pore opening,
ion conduction, and desensitization mechanisms of these receptors. Future studies
regarding these events will likely require molecular simulations of the complete, intact
receptor and would enhance our understanding of the physical and chemical basis for
neural activity.
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